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Saccharomyces cerevisiae can utilize aromatic amino acids as the sole nitrogen source. 
The final products of aromatic amino acid catabolism are aromatic alcohols, including 
tryptophol, phenylethanol, and tyrosol. Production of aromatic alcohols from aromatic 
amino acids is known to proceed via the Ehrlich pathway. It consists of three main steps, 
transamination of an amino acid to an α-keto acid, decarboxylation of an α-keto acid to 
an aldehyde, and reduction of an aldehyde to an alcohol. ARO9 and ARO10 genes 




 In this thesis, the activation mechanisms of ARO9 and ARO10 genes via Aro80, a 
pathway-specific transcriptional activator, and GATA factors, global nitrogen 
regulators, were elucidated.  
Firstly, inducer-dependent activation mechanism of Aro80 was investigated. It was 
found that Aro80 constitutively localized in the nucleus irrespective of the availability 
of inducers such as aromatic amino acids, methionine, or aromatic alcohols. In addition, 
it was demonstrated that Aro80 is constitutively bound to its target promoters and is 
activated by inducers at the level of transactivation. Although Aro80 was also shown to 
bind to its own promoter, ARO80 expression was not induced by tryptophan. 
Secondly, direct involvement of GATA factors in ARO9, ARO10 and ARO80 was 
demonstrated. It was shown that Aro80 is absolutely required for Gat1 binding to the 
ARO9, ARO10, and ARO80 promoters upon TORC1 inhibition by rapamycin treatment. 
Gln3 binding to these promoters showed a partial requirement for Aro80. Rapamycin-
dependent Gat1 and Gln3 binding to the Aro80 target promoters was not affected by 
tryptophan availability, suggesting that transactivation activity of Aro80 is not 
necessary for the recruitment of GATA factors. Rapamycin-dependent induction of 
Aro80 target genes also required PP2A phosphatase complex, but not Sit4 phosphatase, 
acting downstream of TORC1  
Thirdly, it was shown that the transcription of ARO9 and ARO10 is also induced by 
heat shock in an Aro80-dependent manner. However, heat shock-related signaling 
pathways including PKA, PKC, and HOG pathways were not involved in the heat 
shock activation of Aro80. It was elucidated that heat-induced increase in aromatic 




shock. Known aromatic amino acid permeases play an insignificant role in the heat-
induced expression of ARO9 and ARO10, suggesting that an increase in plasma 
membrane fluidity might be responsible for the influx of aromatic amino acids during 
heat shock stress.   
Fourthly, a series of novel inducible promoters were generated based on the ARO9 
promoter. The promoters with various promoter strengths could be generated by 
modulating the number of Aro80 binding site combined with either ARO9 or ARO80 
core promoter. Expression levels from these promoters could be further regulated by 
tryptophan concentration, suggesting potential application of these inducible promoters 
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Chapter 1.  
Research background and 




 Research background  1.1.
Saccharomyces cerevisiae can utilize aromatic amino acids as the sole nitrogen source 
[1,2]. The final products of aromatic amino acid catabolism are aromatic alcohols, 
tryptophol, phenylethanol, and tyrosol, respectively [3,4]. Aromatic alcohol production 
from aromatic amino acids is known to process via the Ehrlich pathway [5]. It consists 
of three main steps, transamination of an amino acid to an α-keto acid, decarboxylation 
of an α-keto acid to an aldehyde, and reduction of an aldehyde to an alcohol. ARO9 and 
ARO10 genes encode transaminase and decarboxylase, respectively, in the Ehrlich 
pathway [6,7]. Tryptophan is converted to tryptophol via three enzymatic steps, where 
phenylalanine and tyrosine are transformed to phenylethanol and tyrosol in a similar 
reaction. Among these aromatic alcohols, tryptophol and phenylethanol act as quorum 
sensing molecules in S. cerevisiae [4,8].  
The transcription of ARO9 gene is induced in the presence of tryptophan, 
phenylalanine, or tyrosine in the growth medium and the level is very low in the 
absence of aromatic amino acids [2,9]. The expression of ARO9 is also modulated by 
nitrogen quality via an ammonia effect [2]. Therefore ARO9 gene appears to be 
regulated in two regulatory pathways by inducers and nitrogen sources, like a well-
known nitrogen catabolite repression (NCR) genes. The promoter of ARO10 gene 
contains a similar sequence of ARO9 promoter [10]. This gene is also subjected to 
aromatic amino acid-dependent induction and regulated by nitrogen quality.   
Previously, research on ARO9 and ARO10 genes has focused towards the 
understanding of the production of aromatic alcohols as quorum sensing molecules in S. 




quality was characterized [2,4,9,11]. However, regulatory mechanism involved in their 
expression has not been well understood 
Aro80 is known as a member of the Zn2Cys6 transcription factor [12,13]. The amino 
acid sequence of Aro80 protein contains several motifs that characterize the Gal4 
family of transcription factors. Tryptophan dependent induction of both ARO9 and 
ARO10 genes is abolished in ARO80 deletion mutant, which indicates the important 
role of Aro80 for the expression of ARO9 and ARO10 under tryptophan treatment [2]. 
However, too little is known about tryptophan-dependent activation mechanism of 
transcription activator Aro80 involved in aromatic amino acid utilization. 
When good nitrogen sources like glutamine, asparagine or ammonia are 
supplemented to the growth medium of S. cerevisiae growing in a poor nitrogen source 
like proline or urea, the transcriptional expression of some enzyme and permease genes 
are involved in the utilization of the poorer nitrogen source is repressed, and their 
corresponding products are inactivated. It is well-known as nitrogen catabolite 
repression (NCR) [1,14]. The transcription of the NCR genes is regulated by the GATA 
transcription factors Gln3 and Gat1 [15,16]. The binding sites of GATA factors in 
NCR-sensitive promoters contain the core GATAA sequence that binds to the well 
characterized zinc finger motif [1,17]. The regulation mechanism of GATA factors is 
exerted at the level of cellular localization, which in some cases correlates with their 
phosphorylation status via TORC1 signaling pathway[16,18]. In previous studies, 
ARO9 and ARO10 were found to be under the control of nitrogen catabolite repression 
[2,19], but the direct roles for GATA factors, Gat1 and Gln3, in this regulation have not 




Heat shock physiologically affects various cellular responses including metabolic 
reprogramming, alteration in cell wall, membrane dynamic, protein aggregation, and 
sequestration [20,21,22]. In addition to the physiological changes, yeast cells respond 
to heat shock by dramatically altering their gene expression programs. Interestingly, 
many of the induced genes by heat shock are not required for heat shock survival. A 
possible elucidation is provided by the observation that the induction of genes by heat 
shock is required not for survival of the stimulating stress but rather for survival of a 
succeeding stress. Also it is well-known that most of the induced genes by heat shock 
are regulated by heat shock factor (Hsf1) and Msn2/4. Sometime Hsf1 and Msn2/4 co-
regulate their target genes [21]. However, too little is known about the heat shock-
dependent activation mechanism of aromatic amino acid utilization genes. 
Promoter engineering is an important part of metabolic engineering [23,24]. In yeasts, 
there are now many promoter systems available that allow one to increase the 
expression of genes by more than 1000-fold and activate gene expression at a 
particular time point during a growth phase. Because expression levels of these 
promoters are extremely low or high, many researches have recently focused on the 
optimization of promoter strengths via promoter engineering [23,25,26]. There are 
many factors that influence the promoter strengths in S. cerevisiae; including the 
sequence context on regulatory motifs, the location of transcription factor binding sites, 
the number of transcription factor binding sites and nucleosome-disfavoring sequences 
[27,28,29,30,31,32]. Therefore, these factors are not only dispensable but, when 
combined together, they are sufficient for developing promoter strengths. Recently, 
hybrid promoter concepts have been conducted to control the promoter strengths in S. 




single upstream activating sequence or tandem upstream activation sequence repeats 
that modulate the promoter strength[34]. These upstream activation sequences help 
localize specific transcription factors that increase the transcriptional activity of the 
core promoter[24]. Therefore the upstream activation sequence (UAS) and core 
promoter regions serve as modular synthetic parts that can be combined to produce a 
strong, functional UAS-core promoter module. For example, it was shown that putative 
Gal4 binding sites were fused individually or in combination with the PLEUM core 
promoter, generating a library of hybrid promoters differing in expression when 
induced by galactose treatment [33].  
 
 The objective of this study 1.2.
S. cerevisiae can utilize aromatic amino acids as the sole nitrogen source. The 
catabolism of aromatic amino acids is known to process via the Ehrlich pathway. The 
degradation of aromatic amino acids consists of three main steps; transamination of an 
amino acid to an α-keto acid, decarboxylation of an α-keto acid to an aldehyde, and 
reduction of an aldehyde to an alcohol. ARO9 and ARO10 genes encode transaminase 
and decarboxylase, respectively, in the Ehrlich pathway. Therefore the expression of 
ARO9 and ARO10 genes are important for cell metabolism. However, the regulatory 
mechanism involved in their expression has not been well understood. In previous 
studies, ARO9 and ARO10 were known to be under the control of nitrogen catabolite 
repression, but the direct roles for GATA factors, Gat1 and Gln3, in this regulation 
have not yet been elucidated. Heat shock physiologically affects various cellular 




dynamic, protein aggregation, and sequestration. In addition to the physiological 
changes, yeast cells respond to heat shock by dramatically altering their gene 
expression programs. However, too little is known about heat shock-dependent 
activation mechanism of transcription activator Aro80 involved in aromatic amino acid 
utilization.  
This thesis focuses on the identification of regulatory mechanism of ARO9 and 
ARO10 genes in response to various ligands and environmental conditions in S. 
cerevisiae. Novel activation factors and their roles were characterized, and regulatory 
mechanisms were studied. In addition, using characterized ARO9 promoter, 













 Amino acids catabolism in S. cerevisiae 2.1.
2.1.1. Eukaryotic transcription factors as direct nutrient sensors  
The zinc finger proteins form one of the largest families of transcriptional regulators 
in eukaryotes. Most of zinc finger proteins interact with target promoters, thereby 
playing crucial roles in transcription and translation. Also zinc finger proteins are 
involved in various cellular processes, including chromatin remodeling, lipid binding, 
protein stabilizing and zinc sensing [12,13]. 
The structure of zinc cluster proteins can be divided into three functional domains: the 
DNA binding domain (DBD), the regulatory domain, and the activation domain (Fig 
2.1 A). Also, the DNA binding domain consists of sub regions: the zinc finger region, 
the linker region, and the dimerization region. It is well-known that these regions are 
required for protein-DNA and protein-protein interactions and specificity for DNA-
binding [13]. Furthermore the activity of zinc cluster proteins is regulated by nuclear-
cytoplasmic shuffling, the affinity of DNA binding, phosphorylation, de-
phosphorylation and unmasking of the activation domain. Some of zinc cluster 
transcriptional regulators are important for the expression of amino acid metabolism 
genes in S. cerevisiae (Fig 2.1 B) [13]. For example, Lue3 is an activator or repressor 
of branched amino acid biosynthesis genes [35,36]. And Cha4 regulates the 
transcription of enzyme genes for catabolism of threonine [37]. Also Lys14 is required 
for expression of lysine synthesis genes [38].  
Especially, Zinc finger transcriptional activator Aro80 positively regulates the 




Figure 2.1 Eukaryotic transcription factors as direct nutrient sensors. 
A. Functional domains of zinc cluster proteins. Zinc cluster proteins can be 
separated into three functional domains: the DBD, the regulatory domain, 
and the acidic region 




acids [2]. ARO9 gene encodes an aromatic aminotransferase II involved in the first 
catabolic step of tryptophan, phenylalanine and tyrosine [39]. ARO10 gene encodes a 
decarboxylase [7]. The transcription of ARO9 and ARO10 is induced in the presence of 
aromatic acids and in the presence of a poor nitrogen source such as urea and proline, 
which is repressed in the presence of a good nitrogen source such as glutamine or 
ammonia [2]. Some branched chain amino acids induce the expression of ARO9 and 
ARO10 via Ehrlich Pathway in S. cerevisiae [9]. 
Ehrlich pathway is a well-known pathway for amino acid catabolism in S. cerevisiae 
(Fig 2.2). In Ehrlich pathway, following transamination of an amino acid into the 
corresponding 2-keto acid, the 2-keto acid decarboxylates to an aldehyde [5,40]. And 
then the aldehydes can be either oxidized by aldehyde dehydrogenases to organic acids 
or reduced by alcohol dehydrogenases to alcohols, which are called fusel alcohols.  
 Especially, S. cerevisiae can utilize aromatic amino acids as a sole nitrogen source 
via Ehrlich pathway, with the main products of their catabolism being tryptophol, 2-
phenethyl alcohol or tyrosol, respectively, which are collectively known as fusel 
alcohols [5]. Aromatic amino acids directly activates transcriptional factor Aro80, 
where Aro80 is required for expression of ARO8 and ARO9 (encodes aromatic 
transaminases) and ARO10 (encodes aromatic decarboxylase). Yeast cells cannot use 
the tryptophan as a sole nitrogen source by deletion of ARO80 gene [2]. It means that 
aromatic amino acid utilization by Ehrlich pathway requires the expression of ARO9 







Figure 2.2 The Ehrlich pathway in S. cerevisiae. 
Catabolism of branched-chain amino acids, aromatic amino and the sulfur-
containing amino acid leads to the formation of fusel acids and fusel alcohols in 




 Target of Rapamycin (TOR) signaling pathway 2.2.
2.2.1. TOR signaling pathway  
S. cerevisiae senses and responds to the environment and amount of available 
nutrients [41]. The target of rapamycin (TOR) kinases belongs to a family of protein 
kinase termed the phosphatidyl inositol kinase-related kinase (PIKK) and functions as 
a key regulator of eukaryotic cell growth in response to nutrient availability [42]. Many 
components in the TOR complexes are highly conserved in yeasts to mammals [41]. 
The target of rapamycin proteins in S. cerevisiae consists of TOR complex1 and TOR 
complex2. TORC1 and TORC2 show a central role in controlling cell growth and cell 
proliferation as part of two distinct signaling branches [41]. Although structurally 
similar, TOR1 and TOR2 are functionally distinguishable. In S. cerevisiae, TOR1 
associates with the conserved proteins Tco89, Kog1 and Lst8 to form TORC1 and 
modulates cell proliferation and the transition between growth and quiescence [41]. 
TOR2 is found generally as a component of TORC2, but it can directly bind to 
TORC1 components under deletion of TOR1. TORC2 consists of Avo1, Avo2, Avo3, 
Bit61, Lst8 and TOR2 and regulates the cell polarity and the organization of the actin 
cytoskeletons [41].   
Rapamycin acts and inhibits cell growth by restricting the function of TORC1 kinase 
activity (Fig 2.3) [43,44]. Rapamycin forms a complex with yeast FKBP12 homologue, 
Fpr1, and this rapamycin-Fpr1 complex directly inhibits TORC1 activity [44]. 
Rapamycin-sensitive TORC1 signaling pathway plays important roles in cell growth 








related genes (Fig 2.3) [41]. Also, inactivation of TORC1 by rapamycin treatment 
mimics the nitrogen starvation condition, leading to the induction of transcription of 
nitrogen catabolite repression (NCR) genes [44]. 
 
2.2.2. Regulation of nitrogen catabolite repression (NCR) by GATA 
factors 
S. cerevisiae can utilize alternative or poor nitrogen sources such as proline, urea, 
allantoin, GABA (γ-aminobutyrate) and arginine when preferred, and good nitrogen 
sources like glutamine, ammonium and asparagine are unavailable in the environment 
[1,44]. In the presence of good nitrogen, transcription of genes encoding the proteins 
needed to transport and degrade poor nitrogen sources does not get induced. On the 
other hand, the absence of good nitrogen sources results in relief of nitrogen repression 
at the transcriptional level of the poor nitrogen catabolite pathways. This phenomenon 
is referred to as nitrogen catabolite repression (NCR) [1]. Regulation of nitrogen 
catabolite repression gene expression in S. cerevisiae is regulated by two positive 
GATA factors; Gln3 and Gat1 and two negative GATA factors; Gzf3 (Deh1) and Dal80 
(Uga43). The central GATAA motif is recognized by four GATA factors to which they 
bind and exert their functions [15,17,45]. In the good nitrogen sources, Gln3 is 
inhibited by their Ure2-dependent sequestration in the cytoplasm (Fig 2.4) [15]. As a 
result, the transcription of NCR genes does not get induced. On the other hand, when 
the nitrogen quantity dwindles, or when poor nitrogen sources exist, Gln3 and Gat1 








transcription of NCR-sensitive genes, required to transport and degrade poor nitrogen 
sources [15].  
The nuclear localization of GATA factors is regulated by TORC1, Ure2, Sit4 and 
PP2A (Fig 2.4) [18,46,47]. Rapamycin treatment or nitrogen starvation condition 
down-regulate TORC1 activity [44]. These conditions activate and release Tap42-Sit4 
or Tap42-PP2A phosphatases from TORC1. Activated Sit4 and PP2A phosphatases 
dephosphorylate Gln3, permitting it to dissociate from Ure2, enter the nucleus and 
activate transcription of NCR genes (Fig 2.4) [44].  
2.2.3. Regulation of GATA factor-mediated transcription by PP2A-
related phosphatases 
Dephosphorylation and localization of GATA factors are regulated by downstream 
serine/threonine phosphatases Sit4 and PP2A [18]. Sit4 is a type 2A-like phosphatase 
catalytic subunit which is active in a complex with the phosphor-protein, Tap42 (Table 
2.1). PP2A phosphatase is composed of a catalytic subunit, Pph21 or Pph22 complexes 
with a scaffold subunit, Tpd3, and one of two regulatory specificity subunits, Cdc55 or 
Rts1. Pph21 or Pph22 can also form complexes with Tap42 (Table 2.1) [48]. Sit4 and 
each PP2A associate with the phosphorylated form of Tor-associated protein, Tap42 
[18]. TORC1 phosphorylates Tap42 under conditions of nitrogen excess. In a good 
nitrogen condition, the Tap42-phosphatase complexes are bound to TORC1 and are 
inactive. During nitrogen starvation or inhibition of TORC1 by rapamycin, the Tap42-
phosphatase complexes are released from TORC1 and thereby become transiently 




Table 2.1 PP2A and PP2A-like phosphatase in S. cerevisiae. 
Phosphatases Function 
Pph3 Catalytic subunit of protein phosphatase PP4 complex 
Tip41 Tip41 regulates protein phosphatase 2A 
Ptc1 Type 2C protein phosphatase 
Tap42-Pph21/22 
Essential protein complex involved in the TOR 
signaling pathway  
Sit4 Type 2A-related serine/threonine phosphatase  
Pph21/22-Tpd3-Cdc55 
Cdc55 : It has multiple roles in mitosis and protein 
 biosynthesis 
Pph21/22-Tpd3-Rts1 
Rts1 : B-type regulatory subunit of protein 





Pph21/22 phosphatase catalytic subunits. These activated phosphatases contribute the 





 Promoter engineering 2.3.
2.3.1. General concept of promoter engineering 
Transcription of gene is controlled by various factors in the organism, including 
transcription factors, various RNA polymerase-associated factors, promoter strength 
and environmental conditions [49]. Obviously, gene expression of mRNA levels may 
not always correspond with enzyme activity given at protein level of regulation, which 
may also be present in the cell. Nevertheless, synthetic control of gene expression is 
important in metabolic engineering fields. Specifically, optimized expressions of key 
pathway enzymes can support and maximize product biosynthesis. The optimization of 
transcriptional regulation occurs at promoter elements that drive gene expression [49]. 
However, native promoters are limited in that they do not maximize the transcription 
levels that are achievable within an organism. To solve this problem, various efforts in 
promoter engineering have shown a great promise both in expanding the 
transcriptional capacity and in enabling tunable expression levels of specific genes 
[50,51]. 
Most metabolic engineering studies in S. cerevisiae have focused on the selection of 
appropriate enzymes because enzyme homologs from various organisms could act 
differently in terms of expression and activity in S. cerevisiae [52]. Therefore selection 
of proper promoters is also important for the optimization of yield and productivity 
[24]. Promoter is important in several aspects of cellular process. Firstly, the 
transcription level of specific protein gene is determined by the promoter strength [49]. 




conditions [49]. Therefore many researchers have attempted to control gene expression 
through promoter engineering.  
2.3.2. Example of promoter selection in metabolic engineering 
applications 
Promoter selection is often a key component of the metabolic engineering. E. coli 
strains are selected as a host system for the overexpression of heterologous proteins 
[53]. In such applications, high strength and tightly controlled promoters are generally 
required to maximize protein production and reduce toxicity during growth phase. The 
end result is that only a few promoters are used for protein production despite hundreds 
of E. coli promoter sequences have been elucidated, including very high strength 
phage-derived promoter systems based on the T7 RNA polymerase and the PL 
temperature-regulated phage promoter systems [53]. Sometimes, the abnormally high 
transcriptional capacity of these systems creates an excessive metabolic load on the E. 
coli host that decreases product formation in other metabolic engineering applications 
[53].  
 Many native promoters have been well characterized in S. cerevisiae. For example, 
strong endogenous constitutive promoters (including PADH, PTEF, PHXT, and PGPD) or 
galactose-inducible promoter; PGAL are usually employed for metabolic engineering 
application including the production of isoprenoids, butanol and various other 
metabolites [54,55,56,57,58]. However these promoters have several disadvantages for 
industrial application including limited inducible promoters, lack of promoter 




2.3.3. Promoter engineering strategy 
Promoter engineering has been an essential tool in basic and applied biological 
research for the development of strains engineered to produce toxic proteins or 
metabolites [50]. However, toxic, expensive or inconvenient inducers using inducible 
promoters can be a limitation on their application. Best inducible promoter for the 
industrial application of yeast must be tightly regulated, express at proper levels after 
induction, inexpensive to induce, and easy to control. However, it is very difficult to 
satisfy all of these requirements. Doxycycline, galactose, copper ions and heat induced 
promoters in S. cerevisiae are actually leaky, inconvenient to use, and require 
expensive, toxic, or difficult-to-provide inducers [24].  
From these reason, various strategies have been attempted to control gene expression 
via promoter engineering including error-prone PCR, saturation mutagenesis of 
nucleotide spacer regions, hybrid promoter engineering and direct modification of 
transcription factor binding sites.  
Error-prone PCR inserts random mutations into specific DNA regions. Error-prone 
PCR performs to an entire promoter region; mutations occur all over the consensus and 
spacer regions of promoter, and lead to a different function [59,60]. This strategy is 
proper to novel promoter variants. This proper selection technique allows the isolation 
of promoters driving a wide range in gene expression. Also, the advantage of this 
approach is relatively easy to generate or improve specific promoters. Saturation 
mutagenesis of nucleotide spacer regions focuses on retaining consensus regions of the 
promoter regions by mutating variable regions. This strategy has been successfully 




Recently, hybrid promoter engineering have been conducted by using several well-
known upstream activation sequence and endogenous core promoter in S. cerevisiae 
[33]. Synthetic hybrid promoters contain a core promoter region fused to a single 
upstream activating sequence or multiple tandem UAS repeats that modulate promoter 
strength. These upstream activation sequence regions recruit transcription factors to 
increase the transcriptional activity of the core promoter. Thus, the UAS and core 
promoter regions perform as modular synthetic parts that can be combined to produce 
various types of UAS-core promoters. In this concept, the strength of hybrid promoter 
can be elevated by either utilizing a stronger core promoter or by increasing the 
number of UAS repeats for the binding of transcription factor. Previously, synthetic 
hybrid galactose-inducible promoters showed a nearly 50-fold range of expression 
levels and additionally increased the transcriptional capacity of the original Gal1 
promoter by about 20% [33]. This approach demonstrates that endogenous promoters 
in yeast can be enhanced simply through the addition of upstream activation elements 
to original core promoters.   
To summarize, error-prone PCR mutagenesis method enables promoter engineering 
by randomly mutating DNA around or within transcription factor binding site on target 
promoters. And mutagenesis of nucleotide spacer regions enables promoter control by 
mutating DNA around conserved DNA motifs. Hybrid promoter engineering relies on 
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 Yeast strains, media, and growth conditions 3.1.
Yeast strains used in this work are listed in Table 3.1. Yeast strains were manipulated 
by PCR-mediated gene targeting method as previously described [61]. Construction of 
genomic TAP-tagged strains was performed as previously described [62]. Yeast cells 
were grown in YPD (1% yeast extract, 2% bacto-peptone, and 2% dextrose) or 
synthetic minimal medium (0.17% yeast nitrogen base without amino acids, 2% 
glucose, and 0.5% ammonium sulfate) supplemented with auxotrophic amino acids 
(histidine, leucine and methionine) and uracil when necessary or yeast nitrogen base 
(YNB) media containing 0.1% glutamine, ammonium sulfate, proline or urea as a sole 
nitrogen source. Rapamycin (Tecoland, USA) was dissolved in DMSO at a 
concentration of 1 mg/ml and used at a final concentration of 0.2 μg/ml. 
 
 Plasmids  3.2.
Plasmid pRS416TEF-ARO80-TAP was generated by cloning a 3.4 kb PCR fragment 
containing ARO80-TAP ORF from BY4741 ARO80-TAP strain into SpeI and XhoI 
sites of pRS416TEF. pRS426ADH-EGFP vector was generated by cloning a 0.75 kb 
PCR fragment containing EGFP ORF into SpeI and BamHI sites of pRS426ADH. 
PCR-amplified ARO80 ORF was cloned into BamHI and SalI sites of pRS426ADH-
EGFP, resulting in pRS426ADH-EGFP-ARO80. ARO80 gene was amplified by PCR 
with reverse primer containing a HA epitope sequence, and then cloned into BamH and 










JHY150 BY4741 BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 EUROSCARF 
JHY151 aro80Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 aro80Δ::KanMX6 EUROSCARF 
JHY152 gln3Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 gln3Δ::KanMX6 EUROSCARF 
JHY153 gat1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 gat1Δ::KanMX6 EUROSCARF 
JHY154 gln3Δgat1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 gat1Δ::KanMX6 gln3Δ::HIS3MX6 This study 
JHY155 gzf3Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 gzf3Δ::KanMX6 EUROSCARF 
JHY156 dal80Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 dal80Δ::KanMX6 EUROSCARF 
JHY157 sit4Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 sit4Δ::KanMX6 EUROSCARF 
JHY158 ure2Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ure2Δ::KanMX6 EUROSCARF 
JHY159 pph21Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pph21Δ::KanMX6 EUROSCARF 
JHY160 pph22Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pph22Δ::KanMX6 EUROSCARF 
JHY161 pph21Δpph22Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pph21Δ::KanMX6 pph22Δ::URA3 This study 
JHY162 tpd3Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 tpd3Δ::URA3 This study 
JHY163 cdc55Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cdc55Δ::URA3 This study 
JHY164 rts1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 rts1Δ::KanMX6 EUROSCARF 
JHY165 rts1Δcdc55Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 rts1Δ::KanMX6 cdc55Δ::URA3 This study 
JHY166 pde2Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pde2Δ::KanMX6 EUROSCARF 
JHY167 ira2Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ira2Δ::KanMX6 EUROSCARF 
JHY168 wsc1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 wsc1Δ::KanMX6 EUROSCARF 
JHY169 rom2Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 rom2Δ::KanMX6 EUROSCARF 
JHY170 sho1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 sho1Δ::KanMX6 EUROSCARF 
JHY171 ssk1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ssk1Δ::KanMX6 EUROSCARF 
JHY172 GAT1-TAP BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 GAT1-TAP His3MX6 
Gaemmaghami 




BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 aro80Δ::KanMX6 GAT1-TAP 
His3MX6 
This study 
JHY174 GLN3-TAP BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Gln3-TAP His3MX6 
Gaemmaghami 




BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 aro80Δ::KanMX6 Gln3-TAP 
His3MX6 
This study 
JHY176 gln3Δgat1Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 gat1Δ::KanMX6 gln3Δ::HIS3MX6 This study 
JHY177 gap1Δagp1Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 gap1Δ::KanMX6 agp1Δ::HIS3MX6 This study 
JHY178 tat2Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 tat2Δ::KanMX6 EUROSCARF 
JHY179 bap2Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 bap2Δ::KanMX6 EUROSCARF 
JHY180 bap3Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 bap3Δ::KanMX6 EUROSCARF 
JHY181 gap1Δ BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 gap1Δ::KanMX6 EUROSCARF 




 Microscopic analysis of protein localization  3.3.
To localize EGFP-Aro80, aro80 cells containing pRS426ADH-EGFP-ARO80 
plasmid were cultured in minimal medium lacking amino acids in the absence or 
presence of tryptophan (50 g/ml) until early log phase. Fluorescence signals were 
detected by fluorescence microscopy (Nikon ECLIPSE Ti-U), and localization of 
nuclei was detected by staining DNA with 2.5 g/ml of 4, 6 diamidino-2-phenylindol 
(DAPI).  
 
 RNA preparation and quantitative RT-PCR (qRT-PCR) 3.4.
Total RNA was isolated from yeast cells and the relative amount of specific mRNA 
was determined by qRT-PCR. Briefly, 2 g of total RNA was subjected to reverse 
transcription in a 30 l reaction mixture containing 200 U of MLV reverse 
transcriptase (M-biotech, Inc., Korea) and 0.1 mg of oligo-dT (M-biotech, Inc., Korea) 
at 42°C for 60 min. Reaction mixture containing 1 l cDNA, 1X SYBR master mix 
(Roche Diagnostics, Germany), and gene-specific primers was subjected to qPCR 
reaction with 45 cycles of 95°C for 10 s, 55°C for 20 s and 72°C for 20 s using Roche 
LightCycler 480 real-time PCR system (Roche Diagnostics, Germany). Primer 





 Chromatin immunoprecipitation (ChIP)  3.5.
ChIP experiment was conducted as previously described with some modifications 
[20]. Cells were cross-linked with 1% formaldehyde for 20 min and quenched with 
glycine at a final concentration of 125 mM for 5 min at 25°C. Cells were washed twice 
with cold TBS [20 mM Tris-HCl (pH7.5) and 150 mM NaCl]. Cells were resuspended 
in 800 l lysis buffer [50 mM HEPES-KOH (pH7.5), 140 mM NaCl, 1 mM EDTA, 1% 
Triton-X 100, 0.1% Na-deoxycholate, 1 mM PMSF, and 1 l protein inhibitor cocktail 
solution]. Glass beads were added to each sample, and then cells were broken by 
vortexing. Lysates were sonicated seven times for 20 sec with amplitude set at 23% 
and centrifuged twice at 13,200 rpm for 10 min. And then 20 l of 50% slurry Ig-G 
agarose bead was incubated with 650 l lysate at 4°C for 3 hr. Beads were washed 
twice in lysis buffer, twice with high salt lysis buffer [50 mM HEPES-KOH (pH7.5), 
500 mM NaCl, 1 mM EDTA, 1% Triton-X 100, 0.1% Na-deoxycholate, 1 mM PMSF, 
and 1 l protein inhibitor cocktail solution], twice with wash buffer [1 mM Tris-HCl 
(pH 8.0), 250 mM LiCl, 0.5% NP40, 0.5% % Na-deoxycholate, and 1 mM EDTA], 
twice with TE buffer [10 mM Tris-HCl (pH 8.0), 1 mM EDTA]. DNA was eluted by 
adding 100 l of elution buffer [50 mM Tris-HCl (pH 8.0), 10 mM EDTA, and 1% 
SDS] and incubating at 65°C for 10 min. Elute was transferred to a fresh tube and 
pooled with 150 l of elution buffer. 100 l elution buffer was added to 50 l of lysate 
for input. Input (IN) and immunoprecipitated (IP) samples were incubated at 65°C for 
overnight, and then DNA was purified using Qiagen PCR purification kit in 55 l of 




samples were analyzed by qRT-PCR, and [IP]/[IN] values were calculated. Primer 
sequences used for ChIP are shown in Table 3.3. 
 
 Protein purification  3.6.
In order to purify GST-Aro80 fusion protein from E. coli (Rosetta gami2 (DE3) 
pLysS), competent cells were transformed with pGEX-4T-1-Aro80 plasmid, and the 
protein were induces with 1 mM IPTG for 3 hr. GST-Aro80 fusion protein was purified 
using glutathione-agarose (Novagen). The purified GST-Aro80 was stored at -70°C 
after dialysis against dialysis buffer containing 50 mM Tris-HCl (pH8.0) and 10% 
glycerol.  
  
 Western blotting  3.7.
Cells were washed twice with TBS buffer [20 mM Tris-HCl (pH7.5) and 150 mM 
NaCl]. Cells were resuspended in 300 l lysis buffer [50 mM Tris-HCl (pH7.5) and 
150 mM NaCl, 0.1% NP40, 1 mM PMSF, and 1 l protein inhibitor cocktail solution]. 
Glass beads were added to each sample, and then cells were broken by vortexing. 
Lysates were centrifuged twice at 13,200 rpm for 10 min. The samples were boiled 
after addition of SDS sample buffer [50mM Tris (pH7.5), 1mM EDTA, and 1% SDS], 
and then subjected to 7% SDS-PAGE. Aro80-TAP and Aro80-HA proteins were 
detected by immunoblotting with mouse anti-IgG-HRP antibody and high affinity rat 




 Electrophoretic mobility shift assay (EMSA)  3.8.
PCR products (10 ng) of ARO9 promoters were radio-labeled with T4 polynucleotide 
kinase in the presence of [γ-32P] dATP and separated from unreacted DNA using 
Probe-Quant™ G-50 Micro columns (GE Healthcare, USA). The labeled probes were 
incubated with GST-tag purified Aro80 at room temperature. The total volume is 20 μL 
containing 20 mM HEPES (pH 7.5), 25 mM potassium acetate, 5% w/v glycerol, 100 
mM KCl, 0.05 mM EDTA, 2 mM MgCl2, 0.5 mM DTT, 0.05% Nonidet P-40 and 0.4 
μg poly(dI-dC). Protein-bound DNA and free DNA were resolved on 5% acrylamide 
gels in 0.5X TBE buffer (45mM Tris-borate and 1mM EDTA) at RT. The gels were 
dried and exposed overnight. The analysis was done with Typhoon 8600 scanner (GE 
Healthcare).  
  
 Determination of the amino acid concentration by using 3.9.
UPLC/QQQ-MS 
To detect intracellular metabolites, samples were prepared as previously described 
with some modifications [63,64,65], and analyzed by UPLC/QQQ-MS. Liquid 
chromatography was performed on a Accela 1250 UPLC™ system (ThermoFisher 
scientific, USA), using Thermo Fisher Hypersil Gold Hilic column (2.1×100 mm, 1.8 
μm, ThermoFisher scientific, USA). The temperatures of column oven and auto-
sampler were maintained at 30°C and 10°C, respectively. The mobile phases were (A) 
5% (vol/vol) acetonitrile, 20 mM ammonium hydroxide, and 20 mM ammonium 




with 15% (A) for 10 min and proceeded to 98% (A) over 28 min and then returned to 
initial conditions, 15% (A), which were maintained for 7 min. The total cycle time was 
35 min, with a flow rate of 400 μ /min and an injection volume of 10 μL using partial-
loop mode. Mass spectrometry was performed using a TSQ quantum Access Max 
triple quadrupole mass spectrometer (ThermoFisher scientific, USA). Ionization was 
performed in the positive and negative switching heated-electrospray (HESI) mode. 
Scan time for SRM transition (dwell time) was 5 ms, each discharge current value was 
4 μA between positive and negative polarity. The conditions used for the ESI source 
were as follows: capillary voltage, 4.0 kV; vaporizer temperature, 40°C; source 
temperature, 270°C; and desolvation temperature, 350°C. Nitrogen was used as the 
sheath gas with a pressure of 30 psi. The collision energy was set at 23 eV. 
ThermoFisher Xcaliver interface was used to control mass spectrometry. Table.1 
shows the component dependent SRM setting for triple quadrupole mass spectrometry 
 
 Gas chromatography 3.10.
To determine metabolite concentration, 1 ml of culture supernatants were collected 
and filtered through a 0.22 μm syringe filter. GC analyses were performed in a Varian 
GC-450 gas chromatograph equipped with a DB-WAX capillary column (30 m×0.32 
mm ID, 0.25 μm film thickness, Agilent) and a flame ionization detector (300 °C). The 
following temperature program was used: isotherm at 40 °C for 5 min, 10 °C/min ramp 
to 170 °C, 30 °C/min ramp to 230 °C and isotherm at 230 °C for 5 min. Acetoin and 





 Measurement of GFP fluorescence intensity  3.11.
The GFP fluorescence intensity of the cells harvested from shake flasks was measured 
using a microplate reader. Briefly, cells were harvested and resuspended with 
phosphate-buffered saline (PBS) to an optimal density between 0.1 and 0.2 at 600 nm, 
and transferred to 96 well plate. Microplate reader analysis was performed using Tecan 
micro-plate reader, and the mean fluorescence intensity distribution of each clonal 
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Yeast cells can use aromatic amino acids as a sole nitrogen source [2]. Aromatic 
amino acids are catabolized to the corresponding alcohols through Ehrlich pathway, 
which consists of three steps; transamination of an amino acid to an α-keto acid, 
decarboxylation of an α-keto acid to an aldehyde, and reduction of an aldehyde to an 
alcohol [5]. Aro9 and Aro10 act as transaminase and decarboxylase, respectively, in the 
Ehrlich pathway. Although Aro9 and Aro10 have been shown to have broad substrate 
specificities, expression of ARO9 and ARO10 genes is highly induced by aromatic 
amino acids, suggesting their important roles in aromatic amino acid catabolism.  
Aro80, a member of the Zn2Cys6 proteins, activates expression of the ARO9 and 
ARO10 genes in response to aromatic amino acids (Fig 4.1) [2]. The Aro80 binding site, 
consisting of four CCG repeats spaced by 7 bp, was initially identified in the promoters 
of ARO9 and ARO10 [66]. Computational analysis of Aro80 ChIP-chip data has 
revealed a putative binding sites of Aro80, WWNCCGANRNWNNCCGNRRNNW, 
which is also identified in the promoters of ARO80 itself and ESBP6 encoding a 
protein homologous to a monocarboxylate permease (Fig 4.2) [10]. In addition to the 
induction by aromatic amino acids, expression of ARO9 and ARO10 is regulated by 
nitrogen source. It has been shown that ARO9 is induced by poor nitrogen source (urea) 
and rapamycin treatment, suggesting that its expression might be under the control of 
NCR. Previously, it has been suggested that GATA factors might regulate ARO9 
indirectly by permease-dependent regulation of cellular inducer levels [2].  
In this chapter, the regulation mechanism of Aro80 target genes via various ligands 








Figure 4.2 The promoter sequences of Aro80 target genes. 




aromatic amino acids activate the expression of ARO9 and ARO10 in an Aro80 
dependent manner. Transcription factor Aro80 always exists in the nucleus irrespective 
of the inducer availability. Also, the localization of Aro80 does not regulate the activity 
of Aro80. Furthermore, it was found that the binding affinity of Aro80 to target 
promoter does not change the existence of ligands in vivo and in vitro. From these 
results, it suggests that Aro80 is constitutively bound to its target promoters and 





 Aro80-dependent expression of ARO9 during growth 4.2.
It was previously reported that the expression of ARO9 and ARO10 genes is regulated 
by transcription activator Aro80 [2]. Yeast cells cannot use a tryptophan as a sole 
nitrogen source in the ARO80 deletion strain because of restriction of expression of 
ARO9 and ARO10. First of all, it was investigated whether the transcription level of 
ARO9 genes is regulated in growth phase. Yeast wild type and aro80Δ cells were 
cultured in synthetic complete media and were harvested at five different time points 
during growth phase.  
There was no difference in growth between wild type and aro80Δ strains (Fig 4.3 A). 
And then transcription levels of ARO9 were compared between wild type and aro80Δ 
cells through RT-PCR. From results, it was found that the expression of ARO9 
gradually increased by growth phase and the expression level of ARO9 highly 
depended on transcription factor Aro80 (Fig 4.3 B).Next, the expression of ARO9 and 
ARO80 genes at different time points in SLAD media was observed (Fig 4.3 C). SLAD 
media contains very low ammonium concentration as a sole nitrogen source. Therefore, 
ammonia in SLAD media as a nitrogen source was rapidly decreased by cell growth. 
Interestingly, the expression of ARO9 was gradually increased and then the highly 
expressed transcript of ARO9 was maintained up to 24 h (Fig 4.3 C). On the other hand, 
expression of ARO80 was rapidly decreased after 8 h (Fig 4.3 C). These results suggest 
two possibilities. First, expressed mRNA of ARO9 is very stable. Second, other 
regulators might be involved in the expression of ARO9 under nitrogen depletion 













Figure 4.3 Aro80-dependent expression of ARO9 during growth. 
A. Growth curve of WT and aro80Δ cells grown in SD media.  
B. Aro80-dependent expression of ARO9. mRNA expression levels were 
detected by RT-PCR. ENO1 was used as a loading control.  
C. Expression levels of ARO9 and ARO80 genes by time points. mRNA 






 Aro80-dependent expression of ARO9 and ARO10 by aromatic 4.3.
amino acids  
 Previously, it was known that aromatic amino acids activated the transcription of 
ARO9 [2]. However, Trp concentration dependent-expression of ARO9 was not 
elucidated. Therefore, it was investigated whether expression levels of ARO9 and 
ARO10 were regulated by tryptophan concentrations. Yeast cells were cultured in 
various concentrations of tryptophan medium as a sole nitrogen source. And then the 
growth rates and the expression levels of ARO9 and ARO10 were observed. Growth 
rates of early exponential phase are noticeably decreased by the increase of tryptophan 
concentrations (Fig 4.4 A). On the other hand, the final cell density increased with 
increasing tryptophan concentrations, which suggest that more tryptophan was used as 
a nitrogen source (Fig 4.4 A). Furthermore, expression levels of ARO9 and ARO10 
genes were increased by increase in the tryptophan concentrations (Fig 4.4 B). These 
results suggest that yeast cells can use tryptophan as a sole nitrogen source via the 








Figure 4.4 Differences in the growth rate and expression levels of ARO9 and 
ARO10 in S. cerevisiae with respect to tryptophan concentrations. 
A. Growth curve of S. cerevisiae in minimal medium with various tryptophan        
concentrations as a sole nitrogen source. 
B. Expression of ARO9 and ARO10 depending on Trp concentration. mRNA 





 Tryptophan independent expression of ARO80 and ESBP6 4.4.
 Aro80, a member of the Zn2Cys6 transcriptional regulator, activates expression of 
the ARO9 and ARO10 genes in response to aromatic amino acids and tryptophol. It was 
previously reported that the binding site of Aro80, consisting of four CCG repeats 
spaced by 7 base pair, was initially identified in the promoters of ARO9 and ARO10 
(Fig 4.2). Also, the 36 bp sequence contains a UAS element necessary and sufficient 
for induced expression of the fusion gene in response to tryptophan [2]. Computational 
analysis of Aro80 ChIP-chip data has revealed a putative binding site of Aro80, 
WWNCCGANRNWNNCCGNRRNNW, which is also identified in the promoters of 
ARO80 itself and ESBP6 encoding a protein homologous to a monocarboxylate 
permease [10]. Therefore ARO80 and ESBP6 genes are potential target of Aro80. 
Especially, ARO80 promoter contains conserved Aro80 binding sites, suggesting a 
potential auto-regulation of its own expression (Fig 4.2). Therefore, it was investigated 
whether expression of ARO80 and ESBP6 genes can be induced by aromatic amino 
acids. Whereas, expression of ARO9 was induced by tryptophan as previously reported, 
and expression of ARO80 and ESBP6 was not affected by the availability of inducer, 
indicating that Aro80 might not activate expression of ARO80 and ESBP6 in response 
to aromatic amino acids (Fig 4.5). This result suggests a requirement of a more detailed 













Figure 4.5 Expression levels of ARO9, ARO80 and ESBP6 by tryptophan. 
BY4741 cells were grown in minimal medium lacking amino acids (− AA) or 
containing 50 μg /ml tryptophan (+ Trp) until early exponential phase. ARO9, 
ARO80 and ESBP6 mRNA levels were analysed by qRT-PCR normalized with 





 Inducer-dependent regulation mechanism of Aro80 4.5.
Environmental signaling can induce the rapid redistribution of transcriptional 
regulators from the cytosol to the nucleus by a number of different mechanisms. In 
order to perform their functions as transcription factors, zinc cluster proteins must be 
localized to the nucleus. Interestingly, it was well known that many zinc cluster 
proteins such as Put3, Oaf1, War1 and Leu3 constitutively localized within the nucleus 
with or without additional signals [67,68,69]. 
To understand the activation mechanism of Aro80, its cellular localization of EGFP-
Aro80 depending on the inducer availability were examined. From result, EGFP-Aro80 
was observed in the nucleus even in minimal medium lacking amino acids, and 
addition of tryptophan to the medium did not elicit any significant changes in Aro80 
localization (Fig 4.6), suggesting that Aro80 always exists in the nucleus irrespective 
of availability of the inducer. Many zinc cluster proteins like Leu3, Put3, War1, Oaf1 
and Lys14 are constitutively localized within the nucleus on a permanent basis. 
Moreover these regulators are also constitutively bound to their target promoters. For 
example, Put3 is a transcriptional regulator of proline utilization genes that encode 
enzymes required for proline catabolism [35,38,70,71]. Although transcriptional 
activator Put3 is always bound to target promoters, the activity of Put3 is regulated by 
direct interaction with proline [70,71,72]. Similarly, transcription factor Ppr1 regulates 
the transcription of pyrimidine biosynthetic pathway related genes. This transcription 
factor is constitutively bound to target promoters in an inactive state but is activated by 











Figure 4.6 Cellular localization of EGFP-Aro80. 
BY4741 cells expressing EGFP-Aro80 were grown in minimal medium lacking 
amino acids (−AA) or containing 50 μg/ml tryptophan (+Trp) until early 
exponential phase, and cellular localizations of EGFP-Aro80 and DAPI-stained 





In addition, a transcription factor Leu3 is bound to target promoters of leucine 
biosynthesis genes. Leu3 is also activated in the presence of α-isopropylmalate, a 
leucine precursor [35].   
Previous results of this study showed that Aro80, like other zinc cluster proteins, is 
also localized in nucleus. However interaction between Aro80 and target promoter 
have still not been elucidated. Therefore, the binding of Aro80 to ARO9 promoter was 
observed. It was investigated whether the binding affinity of Aro80 to the target 
promoters was regulated by the existence of ligands. In order to observe interaction 
between Aro80 and ARO9 promoter, electrophoretic mobility shift assays (EMSA) 
were performed using E. coli purified GST-Aro80 protein (Fig 4.7). From the result, it 
was found that the binding affinity of Aro80 to ARO9 promoter increases in the 
concentration-dependent manner with GST-Aro80. And the binding affinity of Aro80 
to ARO9 promoter was not changed by tryptophol, phenylethanol, tyrosol, tryptophan, 
phenylalanine and tyrosine in vitro (Fig 4.7). It means that ligand is not important for 
target promoter binding of Aro80. Rather, ligands of Aro80 might regulate the activity 
of Aro80 for expression of ARO9 and ARO10.  
The binding of Aro80 to ARO9 promoter was confirmed in vivo by chromatin 
immuno-precipitation (ChIP) experiments. Aro80-TAP could induce expression of 
ARO9 and ARO10 in response to tryptophan, indicating that the TAP-tagged Aro80 is 
functional (Fig 4.8 A, B). Similarly to the in vitro EMSA result, chromatin 
immunoprecipitation (ChIP) analysis showed no significant change in the amount of 




Figure 4.7 Binding affinity of Aro80 to the ARO9 promoter in the absence or 
presence of ligands. 
Binding of GST-Aro80 purified from E. coli to ARO9 promoter was detected by 




Figure 4.8 Functional test of over expressed Aro80-TAP strain. 
A. Growth restoring of yeast cell by the complementation of Aro80-TAP. BY4741 
aro80Δ cells harboring pRS416TEF-ARO80-TAP plasmid were grown in 
minimal medium containing ammonia or tryptophan plate as a sole nitrogen 
source. 
B. Aro80-TAP is functional in tryptophan-dependent induction of ARO9 and 
ARO10. BY4741 aro80Δ cells harboring pRS416TEF-ARO80-TAP plasmid 
were grown in minimal medium lacking amino acids and treated with 500 μg/ml 
tryptophan for 1 h. Aro80-TAP protein expression levels were detected by 
immunoblotting (IB) using anti-mouse IgG-HRP antibody, and the ARO9 and 





Figure 4.9 Binding affinity of Aro80 to ARO9 promoter in vivo. 
ChIP analysis of Aro80-TAP. BY4741 aro80Δ cells expressing Aro80-TAP were 
grown in minimal medium lacking amino acids and treated with 500 μg/ml 
tryptophan for 1 h. Aro80-TAP binding to the ARO9 and control CTT1 promoters 
was analysed by ChIP in the absence (−AA) or presence of tryptophan (+Trp). 
Concentrations of the target promoter DNA in the immunoprecipitated (IP) and 
input (IN) samples were quantified by qPCR. Results are expressed as relative 




vivo results suggest that Aro80 is constitutively bound to its target promoters and 




















In this chapter, it has been shown that the transcription of Aro80 target genes was 
activated by various ligands such as tryptophan, phenylalanine, tyrosine, methionine 
and tryptophol. Although ARO9, ARO10, ARO80 and ESBP6 of promoters have the 
consensus binding motif of Aro80, ligands could not activate the transcription of 
ARO80 and ESBP6. Also, it has been confirmed that GFP-Aro80 was always localized 
in nucleus. In addition, this study found that Aro80 was constitutively bound to its 
target promoters in vivo and in vitro and became activated in the presence of aromatic 








Chapter 5.  
Interplay of Aro80 and GATA 
activators in nitrogen source 






 Introduction  5.1.
Saccharomyces cerevisiae reprograms cellular metabolism in response to the quantity 
and quality of nitrogen sources available in the environment [1,41,73]. Yeast cells can 
use a wide range of compounds as nitrogen sources, but expression of genes for 
utilization of non-preferred nitrogen sources such as proline, allantoin, γ-aminobutyrate 
(GABA) is inhibited in the presence of preferred nitrogen sources such as glutamine 
and ammonia. This global nitrogen quality control is known as nitrogen catabolite 
repression (NCR) [1]. Transcription of NCR-sensitive genes encoding permeases and 
catabolic enzymes of the poor nitrogen sources is regulated by four GATA factors 
consisting of two activators, Gln3 and Gat1/Nil1, and two repressors, Gzf3/Nil2/Deh1 
and Dal80/Uga43, which bind to GATAA sequences in the promoters [74,75]. When a 
good nitrogen source is available, Gln3 and Gat1 are sequestered in the cytosol. In the 
presence of a poor nitrogen source or upon depletion of a good nitrogen source, Gln3 
and Gat1 translocate to the nucleus, leading to activation of the NCR-sensitive genes. 
Although the nitrogen-responsive regulatory mechanisms for Gln3 and Gat1 are not 
completely understood, TOR (target of rapamycin) kinase signaling pathway is in part 
implicated in the regulation of GATA factors [14,76]. TOR kinase, a conserved protein 
kinase from yeast to humans, controls a wide range of metabolic processes in response 
to nutrient availability. In S. cerevisiae, TOR exists in two distinct protein complexes, 
TORC1 and TORC2, of which TORC1 is inactivated by rapamycin. Rapamycin 
treatment mimics the effect of nitrogen limitation, resulting in nuclear localization of 
Gln3 and Gat1, and activation of NCR-sensitive [41]. TORC1-dependent regulation of 
Gln3 localization requires protein phosphatase 2A (PP2A)-like phosphatase [77]. 




a TORC1-Tap42-Sit4 complex formation, which inactivates Sit4 activity. When 
TORC1 is inhibited by rapamycin, Tap42-Sit4 is released from TORC1, and the 
activated Sit4 dephosphorylates Gln3, leading to its dissociation from Ure2 and nuclear 
localization [77]. Although rapamycin induces more prominent nuclear localization of 
Gat1 than Gln3, Sit4 is not absolutely required for rapamycin-dependent Gat1 
localization [78]. In addition to Sit4, PP2A phosphatase functions as a downstream 
effector of TORC1. Active PP2A is composed of a catalytic subunit, Pph21 or Pph22, 
and a regulatory subunit, Cdc55 or Rts1, linked by a scaffolding subunit Tpd3. Pph21 
or Pph22 also forms an active phosphatase complex with Tap42. It has been shown that 
PP2A is involved in rapamycin-dependent nuclear localization of Gln3 and Gat1 in 
glutamine or ammonia grown cells at the level of upstream and downstream of Ure2, 
respectively [79]. Furthermore, PP2A also plays a role in GATA factor binding to the 
nitrogen-responsive promoters upon rapamycin treatment by yet an unknown 
mechanism [80]. 
In this chapter, the novel regulatory mechanism for expression of ARO9 and ARO10 
genes by nitrogen depletion condition was elucidated. Positive GATA factors Gln3 and 
Gat1 directly regulated the expression of ARO9 and ARO10. And Aro80 was required 
for binding of Gat1 and Gln3 to the promoters of ARO9 and ARO10 upon rapamycin 
treatment, suggesting a dominant role for Aro80 in regulating its target genes under 
nitrogen depletion condition. Also it was observed that negative GATA factors were not 





 The characteristic of promoter sequence of Aro80 target genes 5.2.
GATA factors are responsible for nitrogen catabolite repression of genes encoding 
transports and enzymes required to scavenge poor nitrogen sources [1]. Expression of 
NCR-sensitive gene is regulated by the finely tuned and integrated system of the two 
transcription activators (Gln3 and Gat1) and two transcription repressors (Dal803 and 
Gzf3) [1]. Positive GATA factors bind to single GATAA sequence. On the contrary, 
negative GATA factors consist of leucine-zipper domains near their C-terminal and 
form homodimers and heterodimers [1]. Consistent with the formation of dimers, 
Dal80 binding to target promoters requires two GATAAG sequences. Gzf3 also binds 
to target promoters containing single GATAAG sequence in a GATAA sequence-
dependent manner. Integration of the regulation of GATA activators and repressors is 
accomplished by their cross regulation [17].  
 All of Aro80 target gene promoters contain potential GATA binding sites. The 
promoter of ARO9 and ARO10 consist of a single GATAA sequence (Fig 4.2). In the 
case of promoters of ARO80 and ESBP6, they have two GATAA and GATAAG 
sequence motif (Fig 4.2). This observation shows possibility that GATA factors are 








 Aro80, Gat1 and Gln3 are involved in rapamycin-dependent 5.3.
induction of Aro80 target genes 
Previously, it has been suggested that GATA factors might regulate ARO9 indirectly 
through regulation at cellular inducer levels via Gap1 and Agp1 amino acid permeases 
[2]. However, the presence of potential GATA factor binding sites next to the Aro80 
binding sites suggests a direct role for GATA factors in the regulation of Aro80 target 
genes. Therefore, this issue was revisited and the roles of GATA activators were 
examined; Gln3 and Gat1, in regulation of Aro80 target genes upon TORC1 inhibition 
by rapamycin. In agreement with the previous report, rapamycin-dependent induction 
of ARO9 and ARO10 was almost abolished in aro80Δ strain in YPD medium (Fig 5.1 
A). In addition, gln3Δ and gat1Δ strains also showed reduced induction of these genes 
upon rapamycin treatment (Fig 5.1 A). Rapamycin-dependent induction of these genes 
was further reduced in gln3Δgat1Δ double deletion mutant, confirming that both GATA 
factors are involved in activation of these genes. Expression of ARO80 was also 
induced by rapamycin in a GATA factor-dependent manner although the induction fold 
was smaller than those of ARO9 and ARO10 (Fig 5.1 A). Since ARO80 expression is 
independent of inducer levels, GATA factors might directly activate ARO80 expression 
(Fig 5.1 A). The roles for GATA factors in the rapamycin-dependent induction of 
ARO9 and ARO10 might also include transcriptional activation of ARO80 as well as 
the indirect activation of Aro80 as previously proposed.  
Although Gat1 and Gln3 are well known to be regulated by TORC1 signaling 
pathway, the rapamycin-dependent induction of ARO9 and ARO10 genes was not 







Figure 5.1 Aro80, Gat1 and Gln3 are involved in rapamycin-dependent 
induction of Aro80 target genes. 
A. Effects of Aro80, Gat1 and Gln3 on rapamycin-dependent induction of Aro80 
target genes. Cells were cultured in YPD medium until early exponential 
phase and then treated with 0.2 μg /ml rapamycin (Rap) for 1 h. mRNA levels 
of ARO9, ARO10 and ARO80 were determined by qRT-PCR normalized with 
ENO1. Each value represents the average of three independent experiments. 
B. Effect of Gap1 permease on the residual induction of Aro80 target genes in 
gln3Δgat1Δ strain. WT, gln3Δgat1Δ and gln3Δgat1Δgap1Δ strains were grown 
in YPD medium until early exponential phase and then treated with 0.2 μg./ml 
rapamycin (Rap) for 1 h. mRNA levels of ARO9, ARO10 and ARO80 were 
determined by qRT-PCR normalized with ENO1. 
C. Protein expression levels of Aro9 and Aro10 upon rapamycin treatment. Aro9-
TAP and Aro10-TAP stains were cultured in YPD medium until early 
exponential phase and then treated with 0.2 μg /ml rapamycin (Rap) for 1 h. 
Proteins levels of ARO9 and ARO10 were determined by western blot 




role in rapamycin-dependent induction of ARO9 and ARO10, the remaining induction 
in gln3Δgat1Δ might be mediated by Aro80. Stabilization of Gap1, a general amino 
acid permease, could be one of the mechanisms for the increase in amino acids uptake 
upon rapamycin treatment [44], leading to Aro80 activation. In agreement with this 
hypothesis, expression of ARO9 and ARO10 in gln3Δgat1Δ was diminished to basal 
levels in rapamycin-treated cells by additional deletion of GAP1. However, in line with 
the observation that ARO80 is not induced by aromatic amino acids, gln3Δgat1Δgap1Δ 
did not show any significant difference in rapamycin-dependent ARO80 expression 
compared with gln3Δgat1Δ (Fig 5.1 B). Therefore, the residual induction of ARO80 in 
gln3Δgat1Δ is not mediated by the inducer-dependent activation of Aro80, suggesting 
the presence of other yet unidentified regulatory mechanisms. And in this study, Aro9 
and Aro10 protein levels were confirmed by western blot (Fig 5.1 C). From result, 
expression levels of Aro9-TAP and Aro10-TAP were significantly increased by 
rapamycin treatment. Therefore rapamycin treatment contributes the increase of 





 Screening of Aro80 upstream signal transduction pathway 5.4.
 Rapamycin-dependent induction of ARO9 and ARO10 was totally abolished in 
ARO80 deletion strain. Therefore, it was hypothesized that the activation of Aro80 
upon rapamycin treatment is mediated by TOR directly or via mediators [77]. In 
S .cerevisiae, TOR can mediate phosphorylation of yeast AGC kinases. Other non-
AGC kinase proteins are also phosphorylated in a TOR-dependent manner, such as the 
type 2A phosphatase-associated protein 42 (Tap42) and Tip41, Gln3, Npr1 kinase and 
phosphatidylinositol-binding proteins Slm1/2 [77]. Table 5.1 shows TOR regulated 
AGC kinase or non-AGC kinase proteins including various phosphatases. And Table 
5.2 shows various stress response pathway proteins.  
Therefore, it was investigated whether TOR and stress response related proteins 
among these proteins were involved in the activation of Aro80 under rapamycin. From 
result, it was found that deletion of some kinases and phosphatase involved in TORC1 
signaling pathway (SCH9, SKY1, KSP1, RIM15, PPH3, PKH1 and PKH3) did not 
affect the expression of Aro80 target genes upon rapamycin treatment. Although this 
study cannot rule out the possibility that Aro80 is also a target of TORC1 signaling 
pathway, this research could not detect any nitrogen source- or rapamycin-dependent 
changes in Aro80 phosphorylation monitored by protein mobility on SDS-PAGE. 
Therefore, it is not clear yet whether Aro80 is a direct target of TORC1 signaling 
pathway. 
However, the induction of ARO9 was significantly decreased in the deletion of RTS1 
gene (Fig 5.2). It was previously reported that RTS1 gene encodes a regulatory subunit 




Table 5.1 The candidate AGC kinases and non-AGC kinase proteins of Aro80 
upstream signal. 
AGC Kinase Function 
PKC1 Cell wall remodeling during growth 
YPK1/2 
YPK1 : Receptor-mediated endocytosis 
YPK2 : Optimal cell wall integrity 
SCH9 
The transcriptional activation of osmostress-responsive 
genes, G1 progression, cAPK activity and nitrogen 
activation of the FGM pathway 
TPK1/2/3 Ras-cAMP signaling pathway 
CBK1 Cell morphogenesis pathways 
RIM15 
The signal transduction during cell proliferation in 
response to nutrients 
DBF2/DBF20 Cell cycle and morphogenesis 
PKH1/2/3 
The sphingolipid-mediated signaling pathway that controls 
endocytosis 
IPL1 
Aurora kinase subunit of the conserved chromosomal 
passenger complex 
BUB1 The checkpoint regulation 
KIN82 The regulation of phospholipid asymmetry 
YNR047W Regulation of the putative phospholipid translocases  
YBR028C 
Putative protein kinase, possible substrate of cAMP-
dependent protein kinase (PKA) 





KSP1 Filamentous growth 
SKY1 mRNA metabolism and cation homeostasis 
TAP42-PPH21/22 TORC1 downstream phosphatase  
PPH21/22-TPD3-
CDC55 
TORC1 downstream phosphatase  
PPH21/22-TPD3-
RTS1 





Table 5.2 Stress response pathway. 





Negative regulation of STRE 
genes, ion homeostasis 




Upregulation of amino acid 










Quality of N 
source 
Activation of non-preferred 
nitrogen source utilization 




Replenishing of TCA cycle 
components 









Promotion of ribosome biogenesis, 
repression of stress response and 
G0 entrance 






Poor N source Foraging behavior-filamentous gr Snf1, Mep2 





Figure 5.2 Screening of Aro80 upstream signal transduction pathway. 
The effect of various candidates on the ability for expression of ARO9 (A) and 
ARO10 (B) under the condition of rapamycin treatment. WT, various deletion 
mutants were grown in YPD medium until early exponential phase and then 
treated with 0.2 μg/ml rapamycin (Rap) for 1 h. mRNA levels of ARO9 and 




complexes with a scaffold subunit, Tpd3, and one of two regulatory specificity 
subunits, Cdc55 or Rts1. The catalytic activity of Pph21/22 was found to maintain only 
in the presence of Rts1 and Cdc55. It was well-known that DNA binding and nuclear 
localization of GATA factors were regulated by PP2A. Therefore, this result suggests 






 Expression of Aro80 target genes depends on Pph21/22 5.5.
phosphatase complex upon rapamycin treatment  
PP2A and Sit4 phosphatases act downstream of TORC1 pathway to control Gat1 and 
Gln3 at the level of cellular localization and DNA binding [81]. Therefore, the roles for 
Sit4 and PP2A in rapamycin-dependent induction of Aro80 target genes were examined. 
Although rapamycin-dependent DAL5 induction was reduced in sit4Δ as previously 
reported [81], induction of Aro80 targets genes was not much affected by the lack of 
SIT4 (Fig 5.3 A). On the other hand, a double deletion mutant of two PP2A catalytic 
subunit genes, PPH21 and PPH22, showed reduced rapamycin-induced expression of 
ARO9 and ARO10 as well as DAL5 (Fig 5.3 A). Furthermore, deletion of other 
components of PP2A complex; TPD3, CDC55, and RTS1, also conveyed defects in the 
rapamycin-dependent induction of ARO9 and ARO10. In agreement with the central 
role for Tpd3 in PP2A complex formation, tpd3Δ showed similar levels of defects in 
gene induction to those of pph21Δpph22Δ (Fig 5.3 B). The rapamycin-dependent 
induction levels of ARO9 and ARO10 were lower in a double deletion mutant 
cdc55Δrts1Δ than each single deletion mutant (Fig 5.3 B), indicating that both 






Figure 5.3 Expression of Aro80 target genes depends on Pph21/22 phosphatase 
complex upon rapamycin treatment. 
A. Requirement of Pph21/22 phosphatase for rapamycin-dependent induction of 
ARO9 and ARO10. BY4741 wild type, sit4Δ and pph21Δ pph22Δ cells were 
grown in YPD medium until early exponential phase and then treated 0.2 μg/ml 
rapamycin for 1 h. ARO9, ARO10 and DAL5 mRNA expression were quantified 
by qRT-PCR normalized with ENO1. Each value represents the average of three 
independent experiments. 
B. Effects of the components of Pph21/22 phosphatase complex on rapamycin-
induction of ARO9 and ARO10. Rapamycin-induced expression levels of ARO9 




 Gat1 and Gln3 bind to the Aro80 target promoters in an Aro80 5.6.
dependent-manner 
Rapamycin-dependent induction of ARO9 and ARO10 was almost abolished in 
aro80Δ even in the presence of Gln3 and Gat1. This result can be explained if Aro80 is 
a sole regulator involved in the rapamycin-dependent induction of its target genes, and 
the effects of GATA factors are indirect through regulating intracellular inducer levels 
as suggested previously [2]. On the other hand, if GATA factors directly regulate Aro80 
targets genes, Aro80 might be required for the recruitment of GATA factors to the 
promoters.  
To elucidate the regulatory mechanisms, this study investigated binding of Gat1 and 
Gln3 to the Aro80 target promoters by ChIP analyses. Gat1-TAP and Gln3-TAP 
showed increased binding to the ARO9, ARO10, and ARO80 promoters upon 
rapamycin treatment, demonstrating a direct role for Gat1 and Gln3 in their expression 
(Fig 5.4 A, B). However, the rapamycin-dependent recruitment of Gat1 to theses 
promoters was completely abolished in aro80Δ (Fig 5.4 A). Compared with Gat1, Gln3 
showed weaker Aro80 requirement for DNA binding, exhibiting about 50% reduction 
in binding in the absence of Aro80 (Fig 5.4 B). Interestingly, Aro80, which cannot 
activate ARO80 in response to aromatic amino acids, seems to be functional in the 
recruitment of GATA factors to the ARO80 promoter, suggesting that Aro80 
transactivation activity is not absolutely required for the recruitment of GATA factors. 
However, rapamycin-dependent recruitment of Gat1 and Gln3 to the control GAP1 
promoter was not affected by ARO80 deletion (Fig 5.4 A, B). These results suggest that 








Figure 5.4 Gat1 and Gln3 bind to the Aro80 target promoters in an Aro80 
dependent-manner.  
A. Effect of ARO80 deletion on Gat1-TAP binding to the Aro80 target 
promoters. Gat1 binding to the ARO9, ARO10 and ARO80 promoters was 
determined by ChIP. JHY206 (WT Gat1-TAP) and JHY207 (aro80Δ Gat1-
TAP) cells were grown in YPD medium until early exponential phase and 
then treated with 0.2 μg/ml rapamycin for 1 h. The amounts of Gat1-TAP 
bound to the Aro80 target promoters and GAP1 promoter were determined by 
ChIP. The CTT1 promoter was used as a negative control. Results are 
expressed as relative IP/IN values normalized to that of PARO9 in untreated 
wild type. 
B. Effect of ARO80 deletion on Gln3-TAP binding to the Aro80 target 
promoters. Rapamycin-dependent binding of Gln3-TAP to the Aro80 target 
promoters and GAP1 promoter was detected by ChIP in JHY208 (WT Gln3-
TAP) and JHY209 (aro80Δ Gln3-TAP) cells grown in YPD medium. Results 





might be due to the Aro80-dependent binding of Gat1 and Gln3 to the promoters. In 
addition, as discussed above, activation of Aro80 by increased inducer levels might 
also contribute to the effect of Aro80 on the rapamycin-dependent induction of ARO9 





 Aro80 activity is not required for Gat1 and Gln3 binding to the 5.7.
Aro80 target promoters 
Although activity of Aro80 might not be necessary for the recruitment of Gat1 and 
Gln3 to the Aro80 target promoters, it was examined whether Aro80 activity can play 
an additional regulatory role for the binding of GATA factors to ARO9 and ARO10 
promoters. Cells grown in minimal ammonia medium containing increasing amounts 
of tryptophan showed concentration-dependent increase in basal ARO9 expression 
levels, exhibiting up to 30-fold induction in the presence of 100 µg/ml tryptophan 
compared with cells grown in the absence of amino acids (Fig 5.5 A). Treatment of 
rapamycin elicited about 2.3-to 3.2-fold induction of ARO9 expression irrespective of 
tryptophan concentration (Fig 5.5 A), suggesting that activation by GATA factors might 
not be affected by Aro80 activity. Although rapamycin-dependent induction was also 
observed in the absence of amino acids, the induced expression level was negligible 
because of the very low basal expression level of ARO9. The rapamycin-dependent 
induction fold of ARO9 was much lower in minimal medium than YPD medium. 
This study also examined rapamycin-dependent binding of GATA factors to the Aro80 
target promoters in the absence or presence of tryptophan. Rapamycin-induced binding 
of Gat1-TAP and Gln3-TAP to the ARO9, ARO10, and ARO80 promoters was observed 
in a tryptophan-independent manner (Fig 5.5 B, C), demonstrating that Aro80 activity 
might not affect the recruitment of Gat1 and Gln3 to the promoters. Therefore, 
irrespective of its activity, Aro80 binding to the promoters might be enough to allow 








Figure 5.5 Aro80 activity is not required for Gat1 and Gln3 binding to the Aro80 
target promoters. 
A. Effect of tryptophan on ARO9 and ARO80 expression in the absence or presence 
of rapamycin. BY4741 cells were grown in minimal medium lacking amino 
acids or containing the indicated amounts of tryptophan until early exponential 
phase and then treated with rapamycin for 1 h. ARO9 and ARO80 mRNA levels 
were analysed by qRT-PCR normalized with ENO1. 
B. Tryptophan-independent recruitment of Gat1-TAP to the Aro80 target promoters 
upon rapamycin treatment. JHY206 (WT Gat1-TAP) cells were grown in 
minimal medium lacking amino acids (−AA) or containing 50 μg/ml tryptophan 
(+Trp). Gat1-TAP binding to the promoters of Aro80 target genes and GAP1 
was monitored by ChIP before and after rapamycin treatment. The CTT1 
promoter was used as a negative control. Results are expressed as relative IP/IN 
values normalized to that of PARO9 in untreated control (− AA − Rap).  
C. Tryptophan-independent recruitment of Gln3-TAP to the Aro80 target promoters 
upon rapamycin treatment. JHY208 (WT Gln3-TAP) cells were grown in 
minimal medium lacking amino acids (− AA) or containing 50 μg/ml tryptophan 
(+ Trp). Gln3-TAP binding to the promoters of Aro80 target genes and GAP1 
was monitored by ChIP before and after rapamycin treatment. Results are 
expressed as relative IP/IN values normalized to that of PARO9 in untreated 




In addition, it was noticed that the fold increases in the rapamycin-induced Gln3 
binding to the ARO9, ARO10, and ARO80 promoters were lower in minimal medium 
than those in YPD medium approximately by 3-fold (Fig 5.5 C), whereas Gat1 binding 
was largely unaffected by the media types (Fig 5.5 B). Although further studies are 
required to understand the media-dependent differential regulation of Gat1 and Gln3, 
the higher Gln3 binding in YPD medium might contribute to the higher rapamycin-
dependent induction of Aro80 target genes in YPD medium compared with minimal 
medium. In addition, indirect inducer-mediated Aro80 activation might be more 





 GATA factors are not required for Aro80 binding to the promoters 5.8.
Next, it was examined whether GATA factors can affect Aro80 binding to the 
promoters in a reverse way. To this end, the binding affinity of Aro80-HA to Aro80 
target promoters in wild type and gln3Δgat1Δ were compared. For this experiment, 
Aro80-HA was constitutively expressed from ADH1 promoter in the aro80Δ 
background, excluding the effect of the transcriptional induction of ARO80 upon 
rapamycin treatment. Even in the absence of the transcriptional regulation of ARO80, 
ARO9 was induced by rapamycin in a similar manner similar to that observed in wild 
type (Fig 5.6 A). This result suggests that GATA factor-dependent ARO80 induction 
might not play an essential role in the rapamycin-dependent induction of ARO9, 
although it might have some regulatory roles in fine-tuning of the overall regulatory 
network. 
ChIP analyses showed lower binding affinity of Aro80-HA to the ARO80 promoters 
than to the ARO9 and ARO10 promoters (Fig 5.6 B), which might be related to the fact 
that the ARO80 promoter contains only two CCG repeats, while the ARO9 and ARO10 
promoters have four CCG repeats. Although it is weak, Aro80 binding to its own 
promoter might be significant considering the fact that Aro80 is required for the 
recruitment of GATA factors to the ARO80 promoter. Aro80 binding to these promoters 
was not noticeably changed by rapamycin treatment in both wild type and gln3Δgat1Δ 
(Fig 5.7 B). Moreover, Aro80 binding levels to the target promoters were not markedly 
different between wild type and gln3Δgat1Δ. Therefore, while constitutively bound 
Aro80 can facilitate the binding of GATA factors upon rapamycin treatment, GATA 





Figure 5.6 GATA factors are not required for Aro80 binding to the promoters. 
A. Aro80-HA is functional in rapamycin-dependent induction of ARO9. BY4741 
aro80Δ cells expressing pRS415ADH-Aro80-HA were grown in minimal 
medium until early log phase and then the medium was changed to YPD. The 
cells were treated with 0.2 μg/ml rapamycin for 1 h, and ARO9 mRNA levels 
were determined by qRT-PCR normalized to ENO1. 
B. Effects of GATA factors on binding of Aro80-HA to the Aro80 target 
promoters. WT and gln3Δgat1Δ cells expressing Aro80-HA were grown in 
minimal medium until early exponential phase and then treated with 0.2 
μg/ml rapamycin for 1 h. The amounts of Aro80-HA bound to the Aro80 





 Poor nitrogen sources activate transcription of Aro80 target genes 5.9.
The expression levels of ARO9 and ARO10 were also investigated in the presence of 
different nitrogen sources (Fig 5.7). The results showed a typical pattern of NCR, 
exhibiting higher expression levels of ARO9 and ARO10 in the presence of poor 
nitrogen sources such as proline and urea compared with good nitrogen sources like 
glutamine and ammonia (Fig 5.7 A). Addition of tryptophan increased the overall 
expression levels while exhibiting the same nitrogen source-dependent expression 
pattern (Fig 5.7 B). Therefore, although differential regulation of Gat1 and Gln3 in 
response to rapamycin and poor nitrogen source might exert different contribution of 
each GATA factor to the regulation of Aro80 target genes, the interplay between Aro80 
and GATA factors suggested in our model for rapamycin treatment might also be 










Figure 5.7 Poor nitrogen sources activate transcription of Aro80 target genes. 
A. Effect of poor nitrogen sources on transcription of Aro80 target genes. BY4741 
cells were grown to early log phase in minimal medium containing 0.1% 
glutamine, 0.1% ammonium sulfate, 0.1% proline, or 0.1% urea as sole 
nitrogen source. ARO9, ARO10 and DAL5 mRNA expression levels were 
quantified by qRT-PCR normalized with ENO1. 
B. Effect of poor nitrogen sources on transcription of Aro80 target genes in the 
presence of tryptophan. Yeast cells were grown to early log phase in minimal 
medium containing the indicated nitrogen sources and 100 μg/ml tryptophan (+ 
Trp). ARO9, ARO10 and DAL5 mRNA expression were quantified by qRT-
PCR normalized with ENO1. The data showing mRNA expression levels in the 









 Gzf3 and Dal80 negative GATA factors are not involved in 5.10.
rapamycin-dependent induction of Aro80 target genes 
 It is well known that the gene expressions of NCR genes are up-regulated by Gln3 
and Gat1 positive GATA factors [1]. In addition the regulation of the Gln3 and Gat1 
activators, the expression of NCR genes is regulated by the GATA repressors Dal80 
and Gzf3 [81]. Also, it was previously reported that negative GATA factors bind to 
GATAA-containing promoter in vitro. The binding of Dal80 requires two GATAAG 
sequences [82]. On the contrary, Gzf3 can bind a single GATAAG sequence. Because 
the zinc finger DNA binding domain of Dal80 and Gzf3 are greatly homologous with 
those of other GATA activators, this character was expected and that they repress by 
competing with Gat1 or Gln3 for the GATA sites. However the two negative GATA 
factors play very different roles in the regulation of NCR genes. Dal80 regulates the 
expression of NCR genes only in the presence of non-preferred nitrogen source. 
However, Gzf3 regulates the transcription of NCR genes under conditions of nitrogen 
repression.  
In this chapter, it was shown that positive GATA factors are involved in activation of 
ARO9 and ARO10 genes. Thus, the roles for negative GATA factors in rapamycin-
dependent induction of Aro80 target genes were examined. From results, it was found 
that the transcription of ARO9 and ARO10 genes was not affected by deletion of 
dal80Δ or gzf3Δ stains upon rapamycin treatment (Fig 5.8). The expression of DAL5 
significantly was increased in gzf3Δ strain upon rapamycin treatment as previously 
reported (Fig 5.8). Next, it was investigated whether negative GATA factors are 




proline. ARO9 expression was detected in glutamine or proline cultured wild type, 
dal80Δ or gzf3Δ stains. In proline-grown cells, high level DAL5 expression observed in 
dal80Δ or gzf3Δ as previously reported (Fig 5.9). However, the expression of ARO9 
and ARO10 was not changed by deletion of dal80Δ or gzf3Δ under proline media (Fig 
5.9). Results are from experiments with varying conditions and it was concluded that 
negative GATA factors are not involved in the regulation of Aro80 target genes under 














Figure 5.8 Effect of negative GATA factors on expression of ARO9 and ARO10 
genes under rapamycin treatment. 
Effects of Dal80 and Gzf3 on rapamycin-dependent induction of Aro80 target 
genes. WT, dal80Δ and gzf3Δ cells were cultured in YPD medium until early 
exponential phase and then treated with 0.2 μg/ml rapamycin (Rap) for 20 min. 
mRNA levels of ARO9, ARO10 and DAL5 were determined by qRT-PCR 













Figure 5.9 Effect of negative GATA factors on expression of ARO9 and ARO10 
genes under proline media. 
WT, dal80Δ and gzf3Δ cells were grown to early log phase in minimal medium 
containing 0.1% proline as sole nitrogen source. ARO9 and DAL5 mRNA 






Figure 5.10 Model for transcriptional regulation of ARO9 by Aro80 and GATA 
activators.  
Aro80 is bound to the ARO9 promoter even in the absence of inducers (aromatic 
amino acids) and activated by inducers. Upon rapamycin treatment, Gat1 and 
Gln3 are recruited to the promoter in an Aro80-dependent manner irrespective of 
Aro80 activity. The indicated relative ARO9 expression levels are based on the 
data shown in Fig 5.8 A, which were obtained from cells grown in minimal 





  Conclusion 5.11.
In this chapter, it has been shown that transcription of genes involved in catabolism of 
aromatic amino acids is regulated by interplay between Aro80 and GATA activators. 
Aro80 is required for GATA factor binding to the Aro80 target promoters. Although 
many of NCR genes are regulated both positive GATA factors and negative GATA 
factors, negative GATA factors do not affect the expression of ARO9 and ARO10. In 
addition, positive GATA factors might indirectly influence Aro80 activity through 
transcriptional regulation of amino acid permeases importing Aro80 inducers. 
Therefore, GATA factors might play both direct and indirect roles in transcriptional 








Chapter 6.  
Heat shock induces the 
transcription of ARO9 and ARO10 





 Introduction  6.1.
In Saccharomyces cerevisiae, genes involved in the utilization of various nitrogen 
sources are regulated by a global nitrogen quality control known as nitrogen catabolite 
repression (NCR) and by pathway-specific regulators [1]. NCR is mediated by GATA 
transcription factors consisting of two activators (Gat1 and Gln3) and two repressors 
(Gzf3 and Dal80). The NCR-sensitive genes involved in the utilization of alternative 
nitrogen sources are repressed in the presence of good nitrogen sources such as 
glutamine and ammonia, and activated in the presence of poor nitrogen sources such as 
proline and urea[1]. Although it is not completely understood how different nitrogen 
sources regulate GATA factors, TOR (target of rapamycin) kinase signaling pathway is 
in part involved in the negative regulation of Gat1 and Gln3[41].   
Aromatic amino acids are catabolized to the corresponding aromatic alcohols via 
Ehrlich pathway consisting of three steps; transamination of an amino acid to an α-keto 
acid, decarboxylation of an α-keto acid to an aldehyde, and reduction of an aldehyde to 
an alcohol [5]. Aro9 transaminase and Aro10 decarboxylase are involved in the first 
two steps of the aromatic amino acid catabolism via Ehrlich pathway [5]. Transcription 
of the ARO9 and ARO10 genes is regulated both by Aro80, a pathway-specific 
regulator, and by GATA activators. Aro80, a Zn2Cys6 transcriptional activator, 
constitutively binds to the promoters of ARO9 and ARO10, and activates transcription 
in the presence of aromatic amino acids. In addition, it have shown recently that Aro80 
is required for the recruitment of Gat1 and Gln3 to the ARO9 and ARO10 promoters 




In this chapter, a novel Aro80-depedent activation mechanism of ARO9 and ARO10 
expression upon heat shock were demonstrated. It was showed that heat-induced influx 






 Aro80 is activated by heat shock 6.2.
Transcription of the ARO9 and ARO10 genes are regulated by aromatic amino acids 
and nitrogen quality. This study investigated whether other environmental conditions 
can affect the expression of these genes. This study examined the expression of ARO9 
and ARO10 under heat shock, osmotic stress, and glucose starvation conditions. 
Among these stress conditions, only heat shock could activate ARO9 and ARO10 (Fig 
6.1). Heat shock induction of ARO9 and ARO10 in a rich YPD medium was completely 
abolished in aro80Δ strain, suggesting that Aro80 can be activated by heat shock (Fig 
6.1 A). Heat shock induction of HSP26, a target of Msn2/4 and Hsf1 transcription 
factors [84] , was not affected by the lack of ARO80, confirming the specific role for 
Aro80 in heat shock induction of its target genes (Fig 6.1 B). Gln3 and Gat1 directly 
activate the expression of ARO9 and ARO10 in the presence of poor source or 
rapamycin. However, heat shock-dependent induction level of ARO9 was not affected 
in a double deletion mutant gln3Δgat1Δ, indicating that Gln3 and Gat1 are not 











Figure 6.1 Expression of ARO9 and ARO10 is activated by heat shock in an 
Aro80-dependent manner. 
A. Aro80-dependent induction of ARO9 and ARO10 upon heat shock. BY4741 
wild type (WT) and aro80Δ cells, grown in YPD medium at 30°C, were heat 
shocked at 39°C for 10 or 20 min. mRNA expression levels of ARO9 and 
ARO10 were analyzed by qRT-PCR normalized with ACT1. Each value 
represents the average of three independent experiments, and error bars indicate 
standard deviations. 
B.  Expression level of HSP26 upon heat shock. BY4741 wild type (WT) and 
aro80Δ cells, grown in YPD medium at 30°C, were heat shocked at 39°C for 10 
or 20 min. mRNA expression levels of HSP26 were analyzed by qRT-PCR 
normalized with ACT1. Each value represents the average of three independent 
experiments, and error bars indicate standard deviations. 
C.  Effect of Gat1 and Gln3 on the heat shock induction of ARO9. ARO9 mRNA 
expression levels were analyzed by qRT-PCR in WT and gln3Δ gat1Δ before 




 Heat shock activation of genes involved in amino acid catabolism  6.3.
Several NCR genes such as PUT1, PUT2, UGA4, CAR1 and CAR2 are regulated by 
pathway-specific transcription factor upon ligand treatment and general transcription 
factors under nitrogen starvation. Especially, transcription of these genes is rapidly and 
dramatically up-regulated in response to specific amino acid ligands, as well as in 
response to rapamycin which cause TORC1 inactivation.. Because there are similar 
properties between Aro80 target genes and general NCR genes, it was tested whether 
PUT1 and CAR1 genes are regulated by heat shock. Interestingly, results showed that 
expression levels of PUT1 and CAR1 were also increased by heat shock about 4 fold in 













Figure 6.2 Expression of PUT1 and CAR1 is activated by heat shock in an Aro80-
independent manner. 
Aro80-independent induction of PUT1 and CAR1 upon heat shock. BY4741 wild 
type (WT) and aro80Δ cells, grown in YPD medium at 30°C, were heat shocked 
at 39°C for 10 or 20 min. mRNA expression levels of PUT1 and CAR1 were 
analyzed by qRT-PCR normalized with ACT1. Each value represents the average 




 PKA, PKC, and HOG signaling pathways do not affect the heat 6.4.
shock induction of Aro80 target genes  
Protein kinase A (PKA), Protein kinase C (PKC), and high osmolarity glycerol 
(HOG1) signaling pathway are implicated in heat shock response in S. cerevisiae. 
Therefore, it was tested whether these pathways can regulate Aro80 activation upon 
heat shock. PKA activity is up-regulated in pde2Δ and ira2Δ through an increase in 
cAMP levels and decrease in GTP hydrolysis of Ras proteins, respectively. Heat shock 
induction of CTT1, a known target of Msn2/4 which is negatively regulated by PKA 
[85], was reduced in pde2Δ and ira2Δ mutants (Fig 6.3 A). However, expression of 
ARO9 was not much affected by the deletion of PDE2 or IRA2, suggesting that PKA 
pathway might not regulate Aro80 activation. This study also examined the possible 
involvement of Hog1 signaling pathway in heat shock induction of ARO9. However, 
deletion mutants of SHO1 and SSK1 involved in Hog1 signaling pathway [86] showed 
no defect in heat shock induction of ARO9 (Fig 6.3 B). Furthermore, deletion of WSC1 
and ROM2 in protein kinase C (PKC) signaling pathway [87] also showed normal 









 Effect of extracellular amino acids on the heat shock induction of 6.5.
ARO9 
Since heat shock induction of ARO9 in YPD medium was not affected by the known 
signaling pathways, this study hypothesized that heat shock activation of Aro80 might 
be involved in an increase in the availability of aromatic amino acids which act as 
inducers. It was also possible that increasing temperature might affect an increase in 
rate of reaction which up-regulate Aro80 transcription factor activity. Also increase in 
the intracellular amino acid levels can be achieved either by increase in amino acid 
uptake from the medium or by increase in intracellular free amino acids pool possibly 
by protein degradation or autophage. To elucidate the regulatory mechanism, it was 
examined whether ARO9 and ARO10 could be induced by heat shock in the absence of 
aromatic amino acids in the medium. In a minimal medium lacking amino acids (-AA) 
except for auxotrophic supplements (100 μg/ml of each His, Leu, Met, Ura), both basal 
and heat-induced expression levels of ARO9 and ARO10 were lower than those in a 
minimal medium containing amino acids (Fig 6.4). ARO9 and ARO10 were induced by 
3.6 and 1.8 fold, respectively, in the medium lacking aromatic amino acids, but by 7.6 
and 10.1 fold in the presence amino acids in the medium. The increase of Aro80 
activity, protein degradation or autophage might contribute the slight increase of ARO9 
and ARO10 expression in a minimal medium lacking amino acids (-AA).Therefore, 
increase in amino acids uptake rather than internal supply of free amino acids might be 





Figure 6.3 Effect of PKA, PKC and Hog1 signaling pathway on heat shock 
dependent induction of ARO9 gene. 
A. Effect of PKA pathway on the heat shock induction of ARO9. ARO9 and CTT1 
mRNA levels were analyzed by qRT-PCR in WT, pde2Δ, and ira2Δ before and 
after heat shock.  
B. Effect of Hog1 pathway on the heat shock induction of ARO9. ARO9 mRNA 
levels were analyzed by qRT-PCR in WT, sho1Δ, and ssk1Δ before and after 
heat shock. 
C. Effect of PKC pathway on the heat shock induction of ARO9. ARO9 mRNA 





 Heat shock induces an increase in intracellular concentrations of 6.6.
aromatic amino acids 
Next, it was investigated whether intracellular aromatic amino acid concentrations 
can be changed upon heat shock. Cells were grown in the presence or absence of 
amino acids at 30°C, and then heat shocked at 39°C for 15 min. The intracellular 
amino acids levels were detected by mass spectrometry-based analysis. When cells 
were grown in a medium containing amino acids, intracellular Phe, Tyr and Trp 
concentrations were increased by 1.5-fold in average upon heat shock (Fig 6.5). On the 
other hand, for cells grown in the absence of amino acids, the concentrations of Phe 
and Tyr were not significantly changed before and after heat shock, and Trp 
concentration was below the detection limit. These results also support the notion that 





Figure 6.4 Effect of extracellular amino acids on the heat shock induction of 
ARO9 and ARO10. 
Wild type cells were grown in a minimal medium lacking amino acids (-AA) or 
containing amino acids (+AA) until early exponential phase and then heat 
shocked at 39°C for 15 min. ARO9 and ARO10 mRNA levels were analyzed by 




 Amino acid permeases do not affect the heat shock induction of 6.7.
ARO9 and ARO10 
Heat-induced amino acids uptake could be mediated by plasma membrane amino 
acid permeases. On the other hand, it could be a result of heat-induced increase in 
membrane fluidity [88,89], which can facilitate passive influx of amino acids. To 
elucidate the mechanism, the roles of plasma membrane amino acid permeases in the 
heat-induced expression of ARO9 and ARO10 were investigated. It has been known 
that Gap1, Agp1, Tat2, Bap2, and Bap3 permeases are involved in the transport of 
aromatic amino acids [90,91]. However, heat-induced expression levels of ARO9 and 
ARO10 were not significantly changed in the deletion mutants lacking each permease 
(Fig 6.6 A). Furthermore, a double deletion mutant gap1Δagp1Δ, which has been 
shown to have a defect in the Trp-dependent activation of ARO9-lacZ in a urea 
medium [2], also showed normal induction of ARO9 and ARO10 by heat shock (Fig 
6.6 B). These results suggest that amino acid permeases are not involved in the heat-
induced amino acids uptake. Although this study cannot rule out the possibility that 
other amino acid permeases are responsible for the aromatic amino acids uptake 
during heat shock, increase in membrane fluidity might be the major reason for the 
heat-induced amino acid influx, which in turn activates Aro80, leading to the induction 







Figure 6.5 Increase in intracellular aromatic amino acid concentrations upon 
heat shock. 
BY4741 cells were grown in a minimal medium lacking amino acids (-AA) or 
containing amino acid (+AA) until early exponential phase and then heat 
shocked at 39°C for 15 min. Intracellular metabolites were analyzed by 
UPLC/QQQ-MS. Results are presented as fold-increases in Phe, Tyr, and Trp 
concentrations upon heat shock compared with the untreated controls. ND 
indicates not detectable. The mean ± standard deviation of three independent 












Figure 6.6 Effect of amino acid permeases on the heat shock induction of ARO9 
and ARO10.  
A. WT, gap1Δ, agp1Δ, tat2Δ, bap2Δ, and bap3Δ cells grown in YPD medium 
were heat shocked at 39°C for 20 min, and ARO9 mRNA levels were 
analyzed by qRT-PCR 
B. Effect of agp1Δgap1Δ on the heat shock induction of ARO9 and ARO10. 
Heat shock induction of ARO9 and ARO10 mRNA was analyzed by qRT-


























Figure 6.7 Model of heat shock induced expression of ARO9 and ARO10. 
Aro80 is constitutively bound the target promoter. Aro80 is inactive at 30°C. In 
the event of 39°C heat shock condition, influx of aromatic acids in cells leads to 






 Conclusion  6.8.
In this chapter, it has been reported that Aro80 target genes, ARO9 and ARO10, are 
induced by heat shock in an Aro80-dependent manner. However, heat shock-related 
signaling pathways including PKA, PKC, and Hog1 pathways are not involved in the 
heat shock activation of Aro80. It was elucidated that heat-induced increase in amino 
acids influx can lead to the inducer-dependent activation of Aro80 upon heat shock. 
Known aromatic amino acids permeases play a minor role in the heat-induced 
expression of ARO9 and ARO10, suggesting that increase in plasma membrane fluidity 








Chapter 7.  
Promoter engineering by using 







Metabolic pathway is a sequence of biochemical enzyme reactions. Synthetic 
regulation of expression of these enzyme genes is important for metabolic engineering 
parts [30,58,92,93]. One of the key access points to change in metabolic flux is to 
control mRNA quantity at the promoter level [59]. Therefore, selection of appropriate 
promoters is required especially for production yield and efficiency optimization 
[27,52]. Promoter can be defined as specific sequences. It can facilitate the binding of 
transcription factors and enable transcription initiation. The interactions between 
promoter sequence and transcription factors facilitate the recruitment of the 
transcriptional machinery necessary for transcription of a specific gene [49].  
Eukaryotic promoters consist of core element and upstream activation sequence (UAS) 
[49]. The direction and start site of transcription are regulated by the core promoter 
element, and the upstream activation sequence controls promoter strengths and 
frequency. Therefore efficient transcription needs coupling of compatible upstream 
activation sequence and core promoters. Many native promoters have been well-
characterized in S. cerevisiae [93,94,95,96,97,98,99,100]. Especially, strong 
endogenous constitutive promoters (including PADH, PTEF, PHXT, and PGPD) or galactose-
inducible promoters PGAL are usually employed for metabolic engineering application 
[27]. Constitutive promoters offer continuous gene expression levels without the 
requirement of specific inducers. On the other hand, inducible promoters offer a 
complementary method for the control of gene expression usually via the addition of 
inducers. The most widely used inducible promoters for metabolic pathway 




inducible promoters show tight control with 1,000-fold induction between glucose-
repressed and galactose-induced expression [33]. However, PGAL inducible promoters 
have several problems for industrial application. Firstly, the presence of glucose in 
growth media represses the expression of Gal promoter. The transcription of PGAL 
inducible promoters is rapidly induced after culture in non-fermentable carbon sources, 
where this condition usually supports slow growth rate. Secondly, the intracellular 
galactose quantity is gradually decreased by cell growth because of consumption as a 
carbon source. It may lead to reduced expression of PGAL inducible promoters. Thirdly, 
galactose is an expensive carbon source. It is needed in higher concentration for 
efficient expression. Therefore cost of galactose influences the final process cost to a 
large extent. Therefore, galactose promoter is not suitable for a large scale application. 
Although Gal promoter has higher expression levels of target genes by inducer, strong 
overexpression is not always optimal for efficient metabolic flux. Therefore a wide 
range of promoter strengths is required for biotechnological application. Therefore, 
promoter engineering approach is becoming an emerging tool to facilitate this 
optimization and offer more synthetic promoter elements. Prior attempts to modulate 
gene expression include altering endogenous promoter strength through random 
mutagenesis, saturation mutagenesis of nucleotide spacer regions, direct modification 
of TFBS (transcription factor binding site) and hybrid promoter engineering. Among 
these attempts, hybrid promoter engineering has been well-investigated, most recently.    
Synthetic hybrid promoters consist of a core promoter region fused to a single 
upstream activating sequence or tandem upstream activation sequence repeats that 
modulate promoter strength [33]. These upstream activation sequences help localize 




promoter. Therefore the upstream activation sequence (UAS) and core promoter 
regions serve as modular synthetic parts that can be combined to produce a strong, 
functional UAS-core promoter module [33,102]. 
 The expression of ARO9 and ARO10 genes are increased by aromatic amino acids 
via transcriptional activator Aro80. Aromatic amino acids (tryptophan, phenylalanine 
and tyrosine) convert to aromatic alcohols (tryptophol, phenylethanol and tyrosol) 
through aminotransferase Aro9 and decarboxylase Aro10 [5]. Among aromatic 
alcohols, tryptophol, as a quorum sensing molecule, could induce the expression of 
ARO9 and ARO10 in an Aro80-dependent manner. It means that the promoters of 
ARO9 and ARO10 are regulated by positive feedback through substrate (aromatic 
amino acids) and product (tryptophol) [4]. Previously, the character of a UAS element 
that is required for induction of the ARO9 gene has been investigated by using lacZ 
reporter system [2]. This research demonstrated that the 36 bp sequence contains a 
UAS element necessary and sufficient for induced expression of lacZ reporter gene in 
response to tryptophan.  
 Therefore in this chapter, the synthetic promoter engineering approach was 
investigated to the yeast S. cerevisiae by creating several synthetic ARO9 promoter 
variants. Firstly, inducible PARO9-EGFP plasmid was constructed by isolating 36 bp 
Aro80 binding site containing ARO9 core promoter region. Using this construct, 
tryptophan-dependent expression was observed by EGFP signal. Secondly, ARO9 
promoter variants were constructed by using tandem ARO9 UAS and high copy 
number plasmid. These synthetic promoters showed a dynamic range of inducible 
promoter strengths. Finally, ARO9 promoter was applied for the production of acetoin 




and establishes ARO9 variant promoters as a synthetic approach to control of promoter 





 Construction of pARO9-EGFP reporter system 7.2.
The ARO9 promoter is induced by tryptophan treatment via Aro80. Also, the 36-bp 
sequence contains a UAS element necessary and sufficient for induced expression of 
the fusion gene in response to tryptophan. ARO9 UAS contains typical consensus 
binding sequences of Aro80. In this study, by using ARO9 upstream activation 
sequence as an activation module, synthetic hybrid promoter was developed. First of 
all, pARO9-EGFP reporter system was constructed to monitor the expression strengths 
(Fig 7.1 A). And then two and four binding sites of Aro80 were added to the pARO9 
original promoter, creating promoters that contain six and eight Aro80 binding sites. 
Next, a series of ARO9 core promoter-based synthetic promoters were created by 
fusing between one and two binding sites of Aro80 to the original ARO80 UAS. The 





Figure 7.1 Construction of hybrid promoter. 
A. A simplified schematic is provided detailing the construction of hybrid 
promoter-based fluorescence cassettes within the p416-MCS-EGFP 
plasmid backbone 





 Investigating the effect of synthetic ARO9 promoters 7.3.
Next, the strengths of constructed promoters were observed via EGFP signals. Yeast 
cells transformed with pARO9-EGFP and pARO9 variant-EGFP were cultured in the 
presence or absence of tryptophan. Then, EGFP fluorescence signals were observed by 
using a microplate reader.  
The EGFP signal of pARO9-EGFP was increased by treatment of tryptophan in a 
concentration-dependent manner (Fig 7.2). Therefore the strengths of pARO9-EGFP 
can be regulated by tryptophan concentration (Fig 7.2).  
Next, to determine whether this EGFP signal was caused by the increase in the 
transcription, the mRNA expression levels were observed by time points after 
tryptophan treatment. mRNA expression of pARO9-EGFP was gradually increased by 
culture time without tryptophan (Fig 7.3). On the contrary, tryptophan treatment 
rapidly induced expression of EGFP at mRNA level. Therefore, increased EGFP signal 
by tryptophan reflects increase in the transcription from the pARO9 promoter. One 
property of ARO9 promoter is the induction in relatively short period of time; 1 hr, 
after the treatment of tryptophan. 
Next, the EGFP signals of pARO9 WT, +2 Aro80 BS (binding site) and +4 Aro80 BS 
were observed. It was expected that promoter strengths of these promoters increase by 
increasing Aro80 binding sites in the ARO9 promoter. However, the addition of Aro80 




Figure 7.2 Effect of tryptophan concentration on pARO9-EGFP expression. 
pARO9-EGFP construct was tested in medium containing various concentrations 




Figure 7.3 mRNA level measurements of pARO9-EGFP construct.  
Cells were grown in minimal medium lacking amino acids (− AA) or 
containing 200 μg /ml tryptophan (+ Trp) until early exponential phase. 
EGFP mRNA levels were analysed by qRT-PCR normalized with ACT1. 
Each value represents the average ± standard deviation from three 





7.4). Interestingly, EGFP signals were decreased by the addition of Aro80 binding sites 
to the original ARO9 promoter. One possibility of this result is that increased binding 
sites of ARO9 promoter might act as a competition sites of Aro80, preventing its 
functional binding for transactivation. Therefore EGFP signals of pARO9 WT, +2 
Aro80 BS and +4 Aro80 BS were detected in Aro80-overexpressed yeast cells. In this 
case, Aro80 binding site-dependent reduction in EGFP signal was abolished, 
supporting hypothesis of competition binding (Fig 7.5). Although the increase in the 
strength of ARO9 variant promoter could not been developed by the addition of Aro80 
binding sites to ARO9 original promoter, reduction in the strength of promoters were 
found by this experiment. These results demonstrate a possible usage of the variant 
promoters in the reduction of expression. Although the promoter sequences of ARO9 
and ARO80 are very similar, the expression of ARO80 was not affected by tryptophan. 
The difference of ARO80 and ARO9 promoters is the number of Aro80 binding site; 
CCG triplet. The promoter of ARO80 has two Aro80 BS. On the contrary, ARO9 
promoter contains four Aro80 BS. Therefore, it was investigated whether the promoter 
strength of ARO80 promoter was affected by the addition of Aro80 binding site to the 
original ARO80 UAS. However EGFP signals of UASARO80 WT, +1 Aro80 BS and +2 
Aro80 BS were not increased by tryptophan treatment. This result means that ARO80 
promoter does not work properly as a tryptophan inducible promoter.  
As a next step, synthetic hybrid promoter engineering was performed by using Aro80 
binding site and the ARO9 core promoter. One or two Aro80 binding sites of original 
ARO80 promoters were fused to the ARO9 core promoter. Then the EGFP signals of 
UASARO80 WT, +1 Aro80 BS and +2 Aro80 BS were observed. The promoter strengths 




Figure 7.4 Promoter strengths of ARO9 promoter variants. 
Relative fluorescence of EGFP ARO9 promoter variants. Cells were grown in 
minimal medium lacking amino acids (− AA) or containing 200 μg /ml 
tryptophan (+ Trp) until early exponential phase. Error bars represent standard 




Figure 7.5 Promoter strengths of ARO9 promoter variants in Aro80 over-
expressed cells. 
Relative fluorescence of EGFP ARO9 promoter variants under tryptophan 
treatment. Cells were grown in minimal medium lacking amino acids (− AA) or 
containing 200 μg /ml tryptophan (+ Trp) until early exponential phase. Error 





Figure 7.6 Promoter strengths of pARO80 and cARO9 hybrid promoters. 
Relative fluorescence of EGFP pARO80-cARO9 hybrid promoter variants under 
tryptophan treatment. Cells were grown in minimal medium lacking amino acids 
(− AA) or containing 200 μg /ml tryptophan (+ Trp) until early exponential 





Although, addition of UASARO80, containing two Aro80 binding sites, to the ARO9 
promoter showed no increase in induction, addition of one or two Aro80 binding sites 
allowed tryptophan-dependent induction, suggesting that at least three Aro80 binding 
sites are required for induction. In addition, these results suggest that employing 
different number of Aro80 binding sites as hybrid enhancer elements enables 
differential levels of expression. CEN6 (low copy number) and 2 micron-based (high 
copy number) expression plasmids are widely used in yeast for the expression of 
recombinant protein. It has been demonstrated that the regulation of plasmid copy 
number is important for the optimization of metabolic pathway. Therefore the EGFP 
signals of ARO9-EGFP promoter were detected by using low and high copy plasmid. 
From the result, higher EGFP signals were observed in high copy-based pARO9-EGFP 
promoter (Fig 7.7). However, one minor drawback of this system is that it also showed 
increase in the basal expression without tryptophan. In promoter engineering, a tight 
regulation in inducer-specific induction is required, thus further study is needed to 
solve this problem.  
Taken together, the concentration of tryptophan, the number of Aro80 binding site and 
plasmid copy number can regulate the strengths of ARO9 promoter. Moreover, 
combining these factors would provide a wide range of gene expression levels useful 





Figure 7.7 Effect of plasmid copy number on the strength of ARO9 promoter. 
Relative fluorescence of low and high copy pARO9-EGFP under tryptophan 
treatment. Cells were grown in minimal medium lacking amino acids (− AA) or 
containing 200 μg /ml tryptophan (+ Trp) until early exponential phase. Error 






 Application of the tryptophan inducible ARO9 promoter for 7.4.
acetoin and 2, 3-butanediol production  
In B. subtilis, pyruvate is converted into acetoin via α-acetolactate by acetolactate 
synthase (AlsS), α-acetolactate decarboxylase (AlsD). Subsequently, acetoin is reduced 
to 2, 3- butanediol by butanediol dehydrogenase (Bdh). It was recently reported that 
the 2, 3-butanediol biosynthetic pathway from B. subtilis was introduced into the yeast 
strain to produce 2, 3- butanediol from glucose in S. cerevisiae [103].  
Results in this chapter showed that the strength of pARO9-EGFP plasmid can be 
further modified by combining the concentration of tryptophan, the number of Aro80 
binding sites and the copy number of plasmid. To demonstrate the practical application 
of this pARO9 promoter, the plasmid carrying the pARO9-alsS and pARO9-alsD was 
tested for production of acetoin and 2, 3 butanediol in S. cerevisiae. Because EGFP 
signals of pARO9 were affected by tryptophan concentration, pARO9-AlsS and 
pARO9-AlsD transformed yeast cells are cultured with 50 g/ml and 500 g/ml 
tryptophan and without tryptophan (Fig 7.8). Then, the productions of acetoin and 2, 3-
butanediole were detected by gas-chromatography. The productions of acetoin and 2, 
3-butanediol were increased with the increase in concentration of tryptophan, 
suggesting that AlsS and AlsD transcription levels were successfully controlled by 
tryptophan induction.  
In yeasts, there are a limited number of available inducible promoters that can be 
applied to metabolic engineering. Hence, this study shows a possibility of ARO9 





Figure 7.8 Effect of tryptophan concentration on product formation by pARO9 
promoter. 
Acetoin and 2, 3-BD production by pARO9-ALSS and pRO9-ALSD were 




 This newly designed tryptophan-inducible ARO9 promoter is useful for metabolic 







In this chapter, tryptophan-inducible synthetic ARO9 promoters were developed. It 
was shown that the concentration of inducer (tryptophan) and plasmid copy number 
can control the strength of ARO9 promoter via regulation of transcription level. This 
study further enabled fine-tuned tryptophan-induced expression by fusing Aro80 
binding sites to ARO9 core promoter. Especially, Aro80 binding sites can act as 
modular, synthetic transcriptional amplifiers. Production of acetoin and 2, 3 butanediol 
by using ARO9 promoter shows the possibility of biotechnological application. This 
study enabled the production of inducible promoters in S. cerevisiae and has created a 














Most of the genes involved in utilization of alternative nitrogen sources are regulated 
by both pathway-specific regulators and GATA factors governing global regulation. In 
this thesis, the interplay of Aro80, a pathway-specific regulator, and GATA factors was 
elucidated in expression of the ARO9, ARO10 and ARO80 genes which are involved in 
catabolism of aromatic amino acids.  
 
Aro80 is constitutively bound to its target promoters and activated by aromatic 
amino acids 
Aromatic amino acids are known as inducers for Aro80. It was shown that Aro80 is 
constitutively localized in the nucleus and bound to the promoters even in the absence 
of inducers, suggesting that Aro80 might be activated at the level of transcriptional 
activation. Such an activation mechanism is also conserved in Put3, a well-studied 
transcriptional activator of proline utilization pathway. It has been shown that proline 
can directly bind to Put3, inducing its conformational changes, which might unmask 
the C-terminal activation domain of Put3 [70]. Although the direct binding of aromatic 
amino acids to Aro80 has not yet been demonstrated, it is highly likely that aromatic 
amino acids might also act as ligands to activate Aro80 which is already bound to 
DNA. However, such a constitutive binding is not conserved in all Zn2Cys6 family of 
transcription factors involved in catabolism of various nitrogen sources. For example, 
Uga3, a pathway-specific transcription factor for GABA catabolism, binds to its target 
promoters in a GABA-dependent manner along with Dal81, a pleiotropic activator 
[13,104]. It was reported that branched chained amino acids and methionine also 




investigated whether Aro80 is required for the transcriptional activation of ARO9 and 
ARO10 by branched chained amino acids and methionine. It was known that 
transaminase Aro9 and decarboxylase Aro10 enzymes have broad substrate specificity 
and are induced by various amino acids such as aromatic amino acids, branched amino 
acids and methionine. It is possible that their broad substrate specificity may contribute 
to reduce the cellular energy for nitrogen accumulation under nitrogen starvation 
condition.     
It was reported that ARO9 and ARO10 are important for the production of aromatic 
alcohols. It should be noted that ARO9 and ARO10 genes are involved in quorum 
sensing phenomenon via positive feedback production of tryptophol as a quorum 
sensing molecule [4]. In stationary phase, tryptophol accumulates extracellularly as a 
quorum sensing molecule and activates transcription of ARO9 and ARO10 via 
transcription factor Aro80. Therefore, the result from this study can contribute to 
understanding yeast quorum sensing. Recently, a research of 2-phenylehanol 
production was performed based on the regulation mechanism of ARO9 and ARO10 by 
Aro80 and ligands [105]. And production of 2-phenylehanol was successfully 
increased about 70 fold. It means that the results of this study can contribute to 
metabolic engineering field for aromatic alcohol production.      
  
Interplay between Aro80 and GATA factors in regulation of Aro80 target genes. 




lacZ by poor nitrogen source (urea) in the presence of tryptophan inducer [2]. 
However, the role for GATA factors was predicted to be indirectly involved in the 
regulation of inducer uptake. Unlike the previous prediction, our ChIP experiments 
have revealed direct binding of Gat1 and Gln3 to the ARO9, ARO10, and ARO80 
promoters upon rapamycin treatment. Interestingly, the results of this study have 
shown that Aro80 is absolutely required for recruitment of Gat1 to the Aro80 target 
promoters. Gln3 also showed Aro80-dependency in DNA binding although to a lesser 
extent. Transactivational activity of Aro80 seems to be not necessary for inducing 
GATA factor binding to the promoters. In previous studies, the -168 to -133 region of 
ARO9 promoter containing four CCG sequences and one GATAA sequence was shown 
to be sufficient for GATA factor-dependent nitrogen regulation [2]. Therefore, Aro80 
and Gat1 or Gln3 might bind to this region with close proximity especially if all four 
CCG half sites are occupied by two molecules of Aro80 dimer. Although protein-
protein interaction between Aro80 and Gat1 was not confirmed in this study, it is 
possible that rapamycin-dependent physical interaction between Aro80 and GATA 
factors could affect the recruitment of GATA factors to Aro80 target genes. Unlike 
Aro80, Put3 is not absolutely required for rapamycin-dependent induction of PUT1. 
However, phosphorylation of Put3 in the presence of rapamycin or poor nitrogen 
sources has shown to facilitate association of Gat1 to the PUT1 promoter. Since 
rapamycin-dependent induction of Aro80 target genes is not completely abolished in 
gln3Δgat1Δ, it is possible that Aro80 might also be activated by TORC1 inhibition. 
Aro80 activation upon rapamycin treatment could be an indirect effect caused by 
increased intracellular levels of aromatic amino acids. However, it is also possible that 




recruitment of GATA factors to the promoters. Although several Zn2Cys6 family 
proteins are known as phosphoproteins, it still needs further studies to clarify whether 
Aro80 is also regulated by phosphorylation in response to different nitrogen sources. 
Nitrogen regulation of most known NCR-sensitive genes occurs even in the absence of 
inducers. On the contrary, induction of PARO9-lacZ expression in urea medium was 
observed only in the presence of tryptophan [2]. Likewise, it was reported that PARO9-
lacZ was not induced by rapamycin in synthetic medium lacking amino acids. 
However, based on results showing Gat1 binding to the Aro80 target promoters 
irrespective of inducer availability, the apparent lack of nitrogen regulation in the 
absence of inducers might be caused by relatively weak contribution of GATA factors 
in activation of Aro80 target genes. ARO9 expression levels increased gradually as 
increasing Trp concentration in minimal medium, while rapamycin treatment induced 
about 2- to 3- fold increase in ARO9 expression, irrespective of tryptophan 
concentration. Therefore, inducer availability might be a key determinant for 
expression of Aro80 target genes, and Gat1 and Gln3 can further activate transcription 
in the absence of preferred nitrogen sources or upon TORC1 inhibition. This regulatory 
mechanism might allow expression of Aro80 target genes primarily depending on 
substrate availability for the catabolic pathway. 
Beside the regulation of positive GATA factors, expression of NCR gene was 
regulated by negative GATA factors Gzf3 and Dal80 [1,17]. Gzf3 and Dal80 bind to 
GATAA sequence of promoters. Because zinc finger domain of Gzf3 and Dal80 are 
highly homologous to positive GATA factors, it was assumed that negative GATA 
factors repress by competing with Gln3 or Gat1 for the GATAA sites located in the 




roles in the regulation of NCR gene expression [1]. Gzf3 inhibits expression levels of 
NCR genes under nitrogen repression. In contrast, Dal80 limits the activation of NCR 
genes under non-preferred nitrogen source. Previous studies show that the deletion of 
either GZF3 or DAL80 modestly increased DAL5 expression compared to the wild type 
under rapamycin treatment or poor nitrogen source [81]. The results of this study show 
that Dal80 and Gzf3 are not involved in expression of ARO9 and ARO10 under 
rapamycin treatment or poor nitrogen source. Although many of NCR genes are 
regulated both positive GATA factors and negative GATA factors, negative GATA 
factors do not affect the expression of ARO9 and ARO10.   
It has been known that Sit4 and PP2A phosphatases act as downstream effectors of 
TORC1 in regulation of GATA factors [41]. The results of this study have shown that 
PP2A, but not Sit4, is involved in rapamycin-dependent induction of Aro80 target 
genes, possibly by regulating Gat1 and Gln3. These results are consistent with the 
recently identified intranuclear function of PP2A in rapamycin-induced GATA factor 
binding to the DAL5 and GDH2 promoters [80]. Although the detailed mechanisms for 
the PP2A-dependent regulation of GATA factors remain to be elucidated, these results 
suggest that the prevailing Sit4-dependent regulation of Gln3 localization might be 
only a part of the more complicated mode of TORC1-dependent regulation of GATA 
factors. 
In summary, the results of this study have shown that transcription of genes involved 
in catabolism of aromatic amino acids is regulated by mutual regulation between 
Aro80 and GATA activators. Aro80 is required for GATA factor binding to the Aro80 




regulating import of Aro80 inducers. Therefore, GATA factors might play both direct 
and indirect roles in transcriptional regulation of Aro80 target genes.  
  
Heat shock activates transcription factor Aro80 by heat-induced aromatic amino 
acid influx in Saccharomyces cerevisiae 
In this thesis, it was suggested that a novel regulatory pathway for the heat-induced 
gene expression. In addition to regulating classical signal transduction pathways such 
as PKA and PKC, and activating heat shock transcription factor (Hsf1), heat shock 
might affect gene expression via changing intracellular concentrations of various 
metabolites, some of which can function as activators or repressors of various 
transcription factors. Heat shock might affect the profile of cellular metabolites by 
modulating membrane permeability as well as by regulating various metabolic 
pathways, which are also influenced by nutrients and other environmental conditions. 
It was known that detergents are important factors for membrane fluidity. Therefore 
several detergents might stimulate uptake of amino acids by regulating membrane 
fluidity. Comprehensive analysis of the heat-induced changes in metabolite 
concentrations combined with the global gene expression data might provide more 
clear insight into the cellular responses to heat shock. 
 
Promoter engineering by using Aro80 binding sites 
A dynamic range of well-controlled and tunable promoters are required for metabolic 




novel inducible promoter in S. cerevisiae was applied. The utility of this approach with 
three main studies were demonstrated. First, the dynamic range of tryptophan inducible 
promoters was established by using ARO9 promoter. Second, the capacity to impart 
synthetic regulation through a hybrid promoter approach by adding Aro80 binding site 
to UASARO80-PARO9 promoter was demonstrated. Results of this study show that 
strengths of engineered tryptophan inducible promoter are regulated by tryptophan 
concentration and the number of Aro80 binding site. Third, tryptophan inducible ARO9 
promoter was applied for the production of acetoin and 2, 3-butanediol.  
The newly developed ARO9 synthetic promoter would be a useful tool to engineer 
yeast cells for metabolic engineering and synthetic biology. Further optimization of 
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Abstract in Korean 
국문 초록 
 
출아성 효모(Saccharomyces cerevisiae)는 방향족 아미노산을 질소 
원으로 이용할 수 있으며, 방향족 아미노산(tryptophan, phenylalanine, 
tyrosine)은 이화과정을 통하여 방향족 알코올 (tryptophol, 
phenylethanol, tyrosol)로 변환된다. 방향족 아미노산으로부터 방향족 
알코올의 생산은 transamination, decarboxylation, reduction의 3단계 
과정으로 구성되는 Ehrlich pathway를 통하여 이루어지며, 아미노산은 이 
과정을 통하여 순차적으로 α-keto acid, 알데히드, 알코올로 변환 된다. S. 
cerevisiae에서 방향족 아미노산의 Ehrlich pathway 에 관여하는 
transaminase와 decarboxylase는 ARO9과 ARO10 유전자로 알려져 
있다. 본 연구에서는 유도체에 의하여 활성이 조절되는 전사조절인자 
Aro80과 질소 원의 양과 질에 의하여 활성이 조절되는 전사조절인자 
GATA factors에 의한 ARO9과 ARO10 유전자의 발현 기작을 전사 
수준에서 규명하였다.  
 첫 번째로 유도체에 의존적인 Aro80 활성화 기작에 대하여 연구하였다. 
전사조절인자 Aro80는 핵 안에 위치하며, 유도체의 존재 유무는 Aro80의 
세포 내 위치에 영향을 주지 않음을 밝혔다. 또한 Aro80은 목적 유전자의 
프로모터에 결합한 상태로 존재하며, 유도체의 존재가 프로모터 결합력에 
영향을 주지 않음을 규명하였다. 추가적으로 Aro80는 ARO80 유전자의 
프로모터에 결합을 할 수 있으나, 유도체에 의한 ARO80 유전자의 발현에 
영향을 주지 않음을 밝혔다. 
 두 번째로 ARO9, ARO10 그리고 ARO80 유전자 발현이 Gln3와 
Gat1을 포함하는 GATA factor에 의하여 직접적으로 조절됨을 규명하였다. 




ARO10 그리고 ARO80 유전자의 프로모터에 결합이 증가함을 밝혔고, 
이는 Aro80 전사조절인자에 의존적으로 이루어짐을 확인 하였다. 동일한 
조건에서 Gln3는 부분적으로 Aro80을 필요로 하였다. 또한 유도체에 의한 
Aro80의 활성 변화는 Gln3와 Gat1의 Aro80 목적유전자 프로모터로의 
결합에 영향을 주지 않았다. Rapamycin에 의존적으로 조절되는 Aro80의 
목적 유전자의 발현에는 TOR의 하위 신호 전달 체계인 Pph21/22 탈 
인산화 복합체가 필요하며, Sit4 탈 인산화 효소는 영향을 주지 않음을 
규명하였다.     
세 번째로 열충격 스트레스에 의하여 ARO9과 ARO10 유전자의 발현이 
증가하며, 이 또한 Aro80에 의존적으로 조절됨을 확인하였다. 먼저 
열충격에 의한 Aro80의 활성화는 열충격 스트레스와 관련된 신호전달 
체계인 PKA, PKC, HOG에 영향을 받지 않음을 확인하였고, 열충격 
스트레스에 의해 세포 내로 유입된 방향족 아미노산이 유도체에 의한 
Aro80의 활성 증가를 유도함을 밝혔다. 이와 함께 기존에 알려진 방향족 
아미노산 퍼미에이즈(permease)는 열충격 스트레스에 의한 ARO9, 
ARO10 유전자의 발현에 영향을 주지 않음을 확인하였다. 종합적으로 
열충격 과정에서 증가된 세포막의 유동성은 세포 내부로의 방향족 
아미노산의 유입을 유도하고, 이를 통해 활성화된 Aro80이 ARO9, 
ARO10의 유전자 발현을 증가시킨다는 모델 제시하였다. 
 네 번째로 ARO9의 프로모터를 기반으로 한 새로운 유도성 프로모터를 
제시하였다. ARO9 또는 ARO80 코어 프로모터에 Aro80 결합 위치의 
개수를 조절함으로써 다양한 발현 세기를 갖는 프로모터를 제작하였다. 이 
프로모터들의 유전자 발현 수준은 트립토판의 농도를 통하여 조절 할 수 
있다. 본 연구를 통하여 제시된 트립토판 유도 프로모터는 대사 공학에서 
유전자 발현 조절의 용도로 활용 될 수 있을 것이라 기대한다. 
 종합적으로 본 연구에서는 유도체와 다양한 환경적 요인에 의하여 




기반으로 ARO9 프로모터를 이용한 유도성 프로모터의 제작 가능성을 
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